Conference Participation

Posters

Immuno-inflammatory Diseases

Edit Buzás, HCEMM-SU Extracellular Vesicles Research Group

  • Xabier Osteikoetxea: Engineered Cas9 extracellular vesicles as a novel gene editing tool.
    ISEV2022, Lyon, France, 5. 2022.

Prof. András Dinnyés, HCEMM-USZ StemCell Research Group

  • András Dinnyés: Alzheimer disease modelling by hiPSC-derived neurons and microglia like cells.
    International Neuroscience Meeting, Budapest 2022 – IBRO Workshop, Budapest, Hungary, 1. 2022.
  • András Dinnyés: The impact of environmental exposures on the neuronal differentiation of pluripotent stem cells.
    International Neuroscience Meeting, Budapest 2022 – IBRO Workshop, Budapest, Hungary, 1. 2022.
  • András Dinnyés: In vitro neurotoxicological studies using hiPSCs and SH-SY5Y cells.
    International Neuroscience Meeting, Budapest 2022 – IBRO Workshop, Budapest, Hungary, 1. 2022.

Balázs Enyedi, HCEMM-SU Inflammatory Signaling Research Group

  • Balázs Enyedi : Paving the way for the live visualization of chemoattractant gradients – focusing on a novel LTB4 biosensor, GEM-LTB4. Chemotactic Cytokines Gordon Research Conference, Les Diablerets, Switzerland, 6. 2022.

Prof. Attila Gácser, HCEMM-USZ Fungal Pathogens Research Group

  • Attila Gácser: Examining the species-specific host responses of non-tumorous and tumorous oral epithelial cells towards different Candida species at the level of transcriptional regulation.
    GRC – Immunology of fungal infections, Gordon Research Conference, Galveston, Texas, USA, 1. 2023.
  • Attila Gácser: Candida albicans enhances the progression of oral squamous cell carcinoma in vitro and in vivo.
    GRC – Immunology of fungal infections, Gordon Research Conference, Galveston, Texas, USA, 1. 2023.
  • Attila Gácser: Studying the interaction between oral pathogenic bacteria and Candida species at the level of extracellular vesicles.
    Annual Meeting of the Hungarian Society for Microbiology – 2022, Kecskemét, Hungary, 10. 2022.
  • Attila Gácser: Studying trained immunity in human oral epithelial cells.
    51th Annual Meeting of the Hungarian Society for Immunology, Kecskemét, Hungary, 10. 2022.
  • Attila Gácser: Investigation of the interaction of keratinocytes and Candida species.
    51th Annual Meeting of the Hungarian Society for Immunology, Kecskemét, Hungary, 10. 2022.
  • Attila Gácser: Effect of Candida-derived extracellular vesicular treatment on oral squamous cell carcinoma cells.
    HSEV Symposium of Hungarian EV Researchers, Budapest, Hungary, 6. 2022.
  • Attila Gácser: Examining the interaction between oral pathogenic bacteria and Candida species at the level of extracellular vesicles.
    HSEV Symposium of Hungarian EV Researchers, Budapest, Hungary, 6. 2022.
  • Attila Gácser: Effect of Candida-derived extracellular vesicular treatment on oral squamous cell carcinoma cell lines.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, 5. 2022.
  • Attila Gácser: Investigation of the interaction of keratinocytes and Candida species.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, 5. 2022.
  • Attila Gácser: Effect of Candida-derived extracellular vesicular treatment on oral squamous cell carcinoma cell lines.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, 5. 2022.
  • Attila Gácser: Investigation of the interaction of keratinocytes and Candida species.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, 5. 2022.
  • Attila Gácser: Acquired triazole resistance influences virulence properties of C. auris microevolved strains in mouse systemic infection model.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, 10. 2021.
  • Attila Gácser: Investigation of the interaction of keratinocytes and Candida species.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, 10. 2021.
  • Attila Gácser: Characterization and functional analysis of the zinc homeostasis in the human fungal pathogen C. parapsilosis.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, 10. 2021.
  • Attila Gácser: The examination of interaction between Candida species and oral pathogenic bacteria on the level of extracellular vesicles.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, 10. 2021.
  • Attila Gácser: „Tréningelt” immunmemória vizsgálata HPV-KER humán keratinocita sejteken.
    Hungarian Society for Immunology 2021. meeting, Kecskemét, Hungary, 10. 2021.
  • Attila Gácser: Candida eredetű extracelluláris vezikulumok szájüregi laphámsejtes karcinóma sejtvonalakra gyakorolt hatásának vizsgálata.
    Hungarian Society for Immunology 2021. meeting, Kecskemét, Hungary, 10. 2021.

Prof. Lajos Kemény, HCEMM-USZ Skin Research Group

  • Dr. Renáta Bozó: Cell stress-related protein expression is impaired in the uninvolved psoriatic skin.
    50th Annual ESDR Meeting, , 9. 2021.
  • Dr. Beáta Szilvia Bolla: A Cutibacterium acnes hatásának vizsgálata a sebgyógyulási folyamatokra in vitro tenyésztett keratinocitákban.
    49th Annual Meeting of the Hungarian Society for Immunology, , 10. 2020.
  • Fanni Balogh: A veleszületett immunfolyamatok vizsgálata keratinocitákban.
    49th Annual Meeting of the Hungarian Society for Immunology, , 10. 2020.

Bálint Kintses, HCEMM-BRC Translational Microbiology Research Group

József Maléth, HCEMM-USZ Molecular Gastroenterology Research Group

  • József Maléth: Polarity-changed human pancreatic epithelial organoids provide advanced accessibility to apical membrane physiology.
    European Pancreatic Club – The 53rd meeting of EPC, , 6. 2022.
  • József Maléth: The inhibition of the mitochondrial Na+/Ca2+ exchanger prevents acinar cell damage in acute pancreatitis in mice.
    54nd Annual Meeting of EPC, , 6. 2022.
  • József Maléth: Inhibition of Orai1 Ca2+ Channel has a protective role in the progression of chronic pancreatitis and rescues CFTR dysfunction in pancreatic ducts.
    European Cystic Fibrosis Society 17th ECFS Basic Science Conference, Albufeira, Portugal, 3. 2022.
  • József Maléth: Determination of the cytokine pattern of human colon organoids derived from Inflammatory Bowel Disease patients.
    17. European Crohn’s and Colitis Organisation, , 2. 2022.
  • József Maléth: Serum and mucosal Serpin E1 concentration correlates with endoscopic activity in inflammatory bowel disease – potential new activity marker.
    17th Congress of European Crohn’s and Colitis Organisation , Virtual, 2. 2022.
  • József Maléth: Characterizing 2D and 3D organoid cultures derived from mouse and human pancreatic specimens.
    APA (American Pancreatic Association) 2021 Annual Meeting, Eden Roc Miami Beach, USA, 11. 2021.
  • József Maléth: Investigating the role of Orai1 Ca2+ channel in the progression of chronic pancreatitis.
    UEG (United European Gastroenterology) Week, -, 10. 2021.
  • József Maléth: The role of Orai1 Ca2+ channel in the pancreatic ductal epithelial cells under pathophysological conditions.
    UEG (United European Gastroenterology) Week, , 10. 2021.
  • József Maléth: Change in the expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in inflammatory bowel disease.
    16th Congress of European Crohn’s and Colitis Organisation , Virtual, 7. 2021.
  • József Maléth: Disease modelling of Inflammatory Bowel Disease by human colon organoids.
    16. European Crohn’s and Colitis Organisation, , 7. 2021.
  • József Maléth: Characterizing 2D and 3D organoid cultures derived from mouse and human pancreas specimens.
    53rd meeting of the European Pancreatic Club, Verona, Italy, 6. 2021.
  • József Maléth: The role of Orai1 Ca2+ channel in the pancreatic ductal epithel cells under    pathophysological condition.
    European Pancreatic Club – The 53rd meeting of EPC, , 6. 2021.

Karolina Pircs, HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group

  • Abbas Anna: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    PhD Days, Budapest, Hungary, 6. 2023.
  • Balázs Kis: Activation of autophagy by targeting the AMPK pathway as a treatment strategy for Huntington’s disease.
    PhD Days, Budapest, Hungary, 6. 2023.
  • Lea Danics: PHOSPHOPROTEOMIC ANALYSIS REVEALS POST-TRANSCRIPTIONAL DYSREGULATION IN HUNTINGTON’S DISEASE PATIENT DERIVED INDUCED NEURONS.
    PhD Days 2023, Budapest, Hungary, 6. 2023.
  • Vörös Kinga: Felodipine efficiency analysis on induced neurons derived from Huntington’s disease FELL-HD clinical trial patients.
    ENCODS, Faro, 5. 2023.
  • Abbas Anna: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    EMBO-Mechanisms of neuronal remodelling, Kibbuz Nahsholim, Israel, 3. 2023.
  • Lea Danics: PHOSPHOPROTEOMIC ANALYSIS REVEALS POST-TRANSCRIPTIONAL DYSREGULATION IN HUNTINGTON’S DISEASE PATIENT DERIVED INDUCED NEURONS.
    MITT-ANA 2023 Conference, Budapest, Hungary, 2. 2023.
  • Lea Danics: PHOSPHOPROTEOMIC ANALYSIS REVEALS POST-TRANSCRIPTIONAL DYSREGULATION IN HUNTINGTON’S DISEASE PATIENT DERIVED INDUCED NEURONS.
    MITT-ANA 2023 Conference, Budapest, Hungary, 2. 2023.
  • Balázs Kis: Age-related neuronal autophagy changes in induced neurons directly reprogrammed from adult human dermal broblasts.
    HUNDOC 2023, Hungary, 1. 2023.
  • Balázs Kis: Age-related neuronal autophagy changes in induced neurons directly reprogrammed from adult human dermal broblasts.
    HUNDOC 2023, Hungary, 1. 2023.
  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    Semmelweis Symposium , Budapest, Hungary, 11. 2022.
  • Balázs Kis: Activation of autophagy by targeting the AMPK pathway as a treatment strategy for Huntington’s disease.
    Semmelweis Symposium 2022, Hungary, 11. 2022.
  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    HCEMM Symposium , Egerszalók, Hungary, 11. 2022.
  • Balázs Kis: Age-related neuronal autophagy changes in induced neurons directly reprogrammed from adult human dermal broblasts.
    32nd Annual NECTAR Meeting, Greece, 10. 2022.
  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    EHDN2022 Plenary Meeting , Bologna, Italy, 9. 2022.
  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    HUPHAR60: Pharmaceutical Research, Innovation and Pharmacokinetics, Mártafüred, Hungary, 7. 2022.
  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    MÉT 84th Annual Meeting – Annual Conference of the Hungarian Society for Microcirculation and Vascular Biology , Budapest, Hungary, 7. 2022.
  • Balázs Kis: Activation of autophagy by targeting the AMPK pathway as a treatment strategy for Huntington’s disease.
    MÉT – MMVBT 2022, Hungary, 7. 2022.
  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    EMBO Autophagy Workshop, Eger, Hungary, 6. 2022.
  • Danics Lea: RetaiN: Neuroimmunology and stress resistance in human aging and neurodegeneration.
    IBRO22, Budapest, Hungary, 1. 2022.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration.
    IBRO22, Budapest, Hungary, 1. 2022.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance in human aging and neurodegeneration.
    IBRO22, Budapest, Hungary, 1. 2022.

Metabolic and Cardiovascular Diseases

László Csanády, HCEMM-SU Molecular Channelopathies Research Group

  • Balázs Tóth: A TRPM2 CSATORNA N-TERMINÁLIS DOMÉNJÉNEK SZEREPE A CSATORNA KAPUZÁSÁBAN.
    52.Membrán-Transzport Konferencia, Sümeg, 5. 2023.
  • Márton A. Simon: A ΔF508 ÉS G551D CISZTÁS FIBRÓZIST OKOZÓ MUTÁCIÓK HATÁSA A CFTR-PKA KÖLCSÖNHATÁSRA.
    52.Membrán-Transzport Konferencia, Sümeg, 5. 2023.
  • Márton A. Simon: Understanding impact of ΔF508 and G551D CFTR mutations on CFTR/PKA-C interaction.
    67th Biophysical Society Annual Meeting, San Diego, 2. 2023.

Eszter Farkas, HCEMM-USZ Cerebral Blood Flow and Metabolism Research Group

  • Réka Tóth: Infarct size in the subacute phase of experimental focal ischemic stroke does not correspond with functional outcomes.
    31st International Symposium on Cerebral Blood Flow and Metabolism, Brisbane, Australia, 6. 2023.
  • Rita Frank: Nimodipine exerts a protective effect against spreading depolarization and neuroinflammation.
    American Physiology Summit, Long Beach, CA, USA, 4. 2023.
  • Eszter Farkas: Nimodipine accelerates the restoration of functional hyperemia after spreading depolarization.
    European Society for Microcirculation Conference 2023, Aarhus, Denmark, 4. 2023.
  • Szilvia Kecskés: Nimodipine augments cerebrovascular reactivity in aging but runs the risk of intracerebral steal in acute cerebral ischemia.
    European Society for Microcirculation Conference 2023, Aarhus, Denmark, 4. 2023.
  • Eszter Farkas: Nimodipine reduces LPS-induced microglial activation in primary mixed and isolated microglia cell culture. The Joint Meeting of the Hungarian Neuroscience Society (MITT) and the Austrian Neuroscience Association (ANA), Budapest, Hungary, 2. 2023.
  • Eszter Farkas: Nimodipine exerts a neuroprotective effect against spreading depolarization independent of cerebral circulation. The Joint Meeting of the Hungarian Neuroscience Society (MITT) and the Austrian Neuroscience Association (ANA), Budapest, Hungary, 2. 2023.
  • Eszter Farkas: Az asztrocita duzzadás hozzájárul az agykérgi terjedő depolarizáció fókuszainak kiterjedésAz asztrocita duzzadás hozzájárul az agykérgi terjedő depolarizáció fókuszainak kiterjedéséhez és ezáltal a szövetelhaláshoz. A Magyar Anatómus Társaság 2022. évi konferenciája, Szeged, Hungary, 9. 2022.
  • Eszter Farkas: Spreading depolarization disrupts neurovascular coupling after global cerebral ischemia in mice. FENS Forum 2022, Paris, France, 7. 2022.
  • Eszter Farkas: Nimodipine reduces LPS-induced microglial activation in primary mixed and isolated microglia cell culture. FENS Forum 2022, Paris, France, 7. 2022.
  • Eszter Farkas: Nimodipine limits neurovascular dysfunction after spreading depolarization in mice. Brain & Brain PET 2022, Glasgow, Scotland, 5. 2022.
  • Eszter Farkas: The inhibition of spreading depolarization may prevent reperfusion failure after ischemic stroke. Brain & Brain PET 2022, Glasgow, Scotland, 5. 2022.
  • Eszter Farkas: Reduced collateral circulation predicts insufficient reperfusion in the ischemic mouse cerebral cortex. Brain & Brain PET 2022, Glasgow, Scotland, 5. 2022.

Nazha Hamdani, HCEMM-SU Cardiovascular Comorbidities Research Group

Balázs Papp, HCEMM-BRC Metabolic Systems Biology Research Group

  • Lilla Széles, István Magyary: What does the evolution of the mammalian metabolome reveal about human diseases?.
    Straub Days at BRC, Szeged, Hungary, 5. 2023.
  • Kata Dudás: The role of ZBTB1 at the stalled replication fork.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Eszter Ari: Global map of evolutionary dependencies between antibiotic resistance and virulence genes in E. coli.
    Lake Arrowhead Microbial Genomics Conference, Lake Arrowhead, CA, USA, 09.. 2022.
  • Balázs Szappanos: Underground Metabolism As a Rich Reservoir for Pathway Engineering.
    7th Conference on Constraint-Based Reconstruction and Analysis (COBRA 2021), , 3. 2021.
  • Orsolya Liska: Principles of Metabolome Conservation in Mammals.
    7th Conference on Constraint-Based Reconstruction and Analysis (COBRA 2021), , 3. 2021.
  • Roland Tengölics: Accelerated metabolome evolution in Saccharomyces cerevisiae driven by gene content changes.
    Molecular Mechanisms in Evolution and Ecology – Virtual, Heidelberg, Germany, 9. 2020.
  • Zsuzsa Sarkadi: Deleterious mutations as drivers of morphological evolution.
    Molecular Mechanisms in Evolution and Ecology – Virtual, Heidelberg, Germany, 9. 2020.
  • Balázs Papp: Principles of Metabolome Conservation in Mammals.
    Evolutionary Systems Biology 2020, Wellcome Genome Campus conference, Hinxton, UK, 2. 2020.
  • Orsolya Liska: Principles of Metabolome Conservation in Mammals.
    Evolutionary Systems Biology 2020, Wellcome Genome Campus conference, Hinxton, UK, 2. 2020.
  • Balázs Szappanos: The evolution of the yeast metabolome.
    Systems Genetics: From Genomes to Complex Traits, Heidelberg, Germany, 9. 2019.
  • Gábor Grézal: Widespread regulatory rewiring upon antibiotic resistance mutations shapes cross-resistance.
    Systems Genetics: From Genomes to Complex Traits, Heidelberg, Germany, 9. 2019.
  • Roland Tengölics: Rapid Non‐targeted Metabolite Profiling of Yeast.
     ICYGMB2019, Gothenburg, Sweden, 8. 2019.
  • Zsuzsa Sarkadi: Compensatory Mutations Drive Morphological  Evolution.
     ICYGMB2019, Gothenburg, Sweden, 8. 2019.
  • Ádám Györkei: Disorder and surface interactions determine bacterial protein aggregation propensity in vivo.
    2019 Colorado Protein Stability Conference, Colorado, USA, 7. 2019.
  • Eszter Ari: Phylogenetic barriers to horizontal transfer of AMP resistance genes.
    Molecular Mechanisms in Evolution (GRS), Gordon Research Seminar, Easton, USA, 6. 2019.
  • Eszter Ari: Phylogenetic barriers to horizontal transfer of AMP resistance genes.
    Molecular Mechanisms in Evolution, Gordon Research Conference, Easton, USA, 6. 2019.

Zoltán Varga, HCEMM-SU Cardiometabolic Immunology Research Group

  • Ágnes Paál: Effects of Blunting Annexin A1 Expression in Small Cell Lung Cancer Cell Lines.
    19th World Congress of Basic and Clinical Pharmacology, Glasgow, Scotland, 7. 2023.
  • Kucsera Dániel: Effects of an immune checkpoint inhibitor on cardiac function in an aged multi-morbid setting.
    World Congress of Pharmacology, Glasgow, Scotland, 7. 2023.
  • Tamás Gergely: Tamás G. Gergely, Dániel Kucsera, Viktória E. Tóth, Tamás Kovács, Nabil V. Sayour, Zsófia D. Drobni, Mihály Ruppert, Balázs Petrovich, Bence Ágg, Zsófia Onódi, Nóra Fekete, Éva Pállinger, Edit I. Buzás, Laura I. Yousif, Wouter C. Meijers, Tamás Radovits, Béla Merkely, Péter Ferdinandy, Zoltán V. Varga.
    WCP 2023, Glasgow, 7. 2023.
  • Kocsis Márton: Thymus activation may affect cardiotoxicity caused by anti PD-1 therapy.
    FAMÉ, Mátraháza, Hungary, 6. 2023.
  • Kovács Tamás: THE COMBINED USE OF IMMUNE CHECKPOINT INHIBITORS AND OLAPARIB TO REDUCE CARDIOTOXIC SIDE EFFECTS .
    FAMÉ 2023, Mátraháza, 6. 2023.
  • Ágnes Paál: Effects of Blunting Annexin A1 Expression in Small Cell Lung Cancer Cell Lines.
    PhD Scientific Days, Budapest, Hungary, 6. 2023.
  • Kovács Tamás: THE COMBINED USE OF IMMUNE CHECKPOINT INHIBITORS AND OLAPARIB TO REDUCE CARDIOTOXIC SIDE EFFECTS .
    PhD Scientific Days, Semmelweis University, Budapest, 6. 2023.
  • Ágnes Paál: Effects of Blunting Annexin A1 Expression in Small Cell Lung Cancer Cell Lines.
    FAMÉ2023, Mátraháza, Hungary, 6. 2023.
  • Tamás Gergely: CARDIOTOXICITY OF ANTI-PD-1 IMMUNE CHECKPOINT INHIBITOR IN MICE WITH PRIOR CARDIAC ISCHEMIC INJURY.
    FAMÉ, Mátraháza, 6. 2023.
  • Onódi Zsófia: INFLAMMASOME ACTIVITY IN THE SKELETAL MUSCLE AND HEART OF RODENT MODELS FOR DUCHENNE MUSCULAR DYSTROPHY.
    PhD napok 2023, Budapest, Hungary, 6. 2023.
  • Kucsera Dániel: IL‑1β inhibition prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH.
    PhD napok, Budapest, Hungary, 6. 2023.
  • Viktória E. Tóth: Gene expression alterations of different SARS-CoV-2 host factors in heart failure patients .
    19th World Congress of Basic&Clinical Pharmacology 2023, Glasgow, Scotland, 7. 2023.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by Next Generation Sequencing and validated by droplet digital PCR .
    HCEMM Symposium 2022, Egerszalók, Hungary, 11. 2022.
  • Tamás Gergely: Investigating the role of immune checkpoint molecules in heart failure.
    HCEMM Symposium 2022, Egerszalók, Hungary, 11. 2022.
  • Vörös Imre: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients.
    HCEMM PhD Symposium 2022, Egerszalók, Hungary, 11. 2022.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by Next Generation Sequencing and validated by droplet digital PCR .
    Cardioimmunology Zürich 2022, Zürich, Switzerland, 9. 2022.
  • Tamás Gergely: Molecular determinants of immune checkpoint inhibitor-induced cardiac dysfunction: comparison of PD-1 inhibitor treated C57BL/6J and BALB/c mice.
    Cardioimmunology Zürich 2022, Zürich, Switzerland, 9. 2022.
  • Kucsera Dániel: Effects of immune checkpoint inhibitor on cardiac function in an aged multi-morbid setting.
    Cardioimmunology 2022, Zürich, Switzerland, 9. 2022.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by Next Generation Sequencing and validated by droplet digital PCR .
    PhD Scientific Days, Semmelweis University, Budapest, Hungary, 7. 2022.
  • Tamás Gergely: Molecular determinants of immune checkpoint inhibitor-induced cardiac dysfunction: comparison of PD-1 inhibitor treated C57BL/6J and BALB/c mice.
    PhD Scientific Days, Semmelweis University, Budapest, Hungary, 7. 2022.
  • Vörös Imre: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients.
    PhD Scienctific Days, Semmelweis, Budapest, Hungary, 7. 2022.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by Next Generation Sequencing and validated by droplet digital PCR .
    ISHR World Congress 2022, Berlin, Germany, 6. 2022.
  • Tamás Gergely: Molecular determinants of immune checkpoint inhibitor-induced cardiac dysfunction: comparison of PD-1 inhibitor treated C57BL/6J and BALB/c mice.
    ISHR World Congress 2022, Berlin, Germany, 6. 2022.
  • Dániel Kucsera: Evaluation of the interplay between NASH and HFpEF in varied murine age groups.
    FCVB 2022, Budapest, Hungary, 4. 2022.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients.
    FCVB 2022, Budapest, Hungary, 4. 2022.
  • Kucsera Dániel: Evaluation of the interplay between NASH and HFpEF in varied murine age groups.
    FCVB 2022, Budapest, Hungary, 4. 2022.
  • Nabil V. Sayour: Limb remote ischemic preconditioning in rats: discrepancy between meta-analysis and a three-centre in vivo study.
    Frontiers in Cardiovascular Biomedicine, Budapest, Hungary, 4. 2022.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6J mice.
    FCVB 2022, Budapest, Hungary, 4. 2022.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac.
    FCVB 2022, Budapest, Hungary, 4. 2022.
  • Vörös Imre: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients.
    FCVB 2022, Budapest, Hungary, 4. 2022.
  • Zsófia Onódi : Transcriptomic analysis and comparative characterization of rat H9C2, human AC16 and murine HL-1 cardiac cell lines.
    FCVB2022, Budapest, Hungary, 4. 2022.
  • Dániel Kucsera: Investigating the efficacy of anti IL 1ß monoclonal antibody treatment in an aged mouse model of non alcoholic steatohepatitis.
    EPHAR 2021, Prague, 12. 2021.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors on a human cardiomyocyte cell line as well as on samples from chronic heart failure patients.
    EPHAR 2021, Prague, 12. 2021.
  • Dániel Kucsera: Investigating the efficacy of anti IL 1ß monoclonal antibody treatment in an aged mouse model of non alcoholic steatohepatitis.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors on a human cardiomyocyte cell line as well as on samples from chronic heart failure patients.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Zsófia Onódi : Transcriptomic analysis and comparative characterization of rat H9C2, human AC16 and murine HL-1 cardiac cell lines.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Dániel Kucsera: Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-specific differences in Inflamma􀆟on, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice.
    PhD napok 2021, Budapest, Hungary, 7. 2021.
  • Zsófia Onódi : Transcriptomic analysis and comparative characterization of rat H9C2, human AC16 and murine HL-1 cardiac cell lines.
    PhD Days 2021, Budapest, Hungary, 7. 2021.
  • Zsófia Onódi : NLRP3-INDEPENDENT INFLAMMASOME ACTIVATION IN HEART FAILURE.
    PhD Days 2020, Budapest, Hungary, 8. 2020.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidil-peptidase-4 inhibitors on a human cardiomyocyte cell line as well as on samples from chronic heart failure patients.
    SEMMELWEIS SYMPOSIUM 2019, Budapest, Hungary, 11. 2019.
  • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
    SE Symposium 2019, Budapest, Hungary, 11. 2019.
  • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
    EMBL Meeting 2019, Barcelona, Spain, 9. 2019.
  • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
    ESCWG, Naples, Italy, 5. 2019.

Nikolett Wohner, HCEMM-SU Thrombosis and Hemostasis Research Group

Lamsa Karri, Human neuron physiology and therapy Core Group

  • Emoke Bakos: HCN channels at the somatic membrane regulate input–output function of human neocortex fast-spiking interneurons.
    FENS Regional meeting, Algarve, Portugal, 5. 2023.
  • Emoke Bakos: HCN channels at the somatic membrane regulate input–output function of human neocortex fast-spiking interneurons.
    FENS Regional meeting, Algarve, Portugal, 5. 2023.
  • Emoke Bakos: HCN channels at the somatic membrane ensure rapid input–output function of human neocortex fast-spiking interneurons.
    Joint Meeting of the Hungarian Neusoscience Society and the Austrian Neuroscience Association, MITT-ANA conference Budapest, Hungary, 2. 2023.
  • Joanna Sandle: Metabotropic glutamate receptor mediated modulation of excitatory synaptic transmission shows interneuron specificity in the human cortex.
    Joint Meeting of the Hungarian Neusoscience Society and the Austrian Neuroscience Association, MITT-ANA conference Budapest, Hungary, 2. 2023.
  • Melinda Gazdik: Differential regulation of static firing responses vs. synaptic integrationin physiologically distinct classes of subiculum neurons.
    Joint Meeting of the Hungarian Neusoscience Society and the Austrian Neuroscience Association, MITT-ANA conference Budapest, Hungary, 2. 2023.
  • Emoke Bakos: HCN channels at the somatic membrane regulate input–output function of human neocortex fast-spiking interneurons.
    HCEMM PhD student symposium, Eger, Hungary, 11. 2022.
  • Emoke Bakos: HCN channels at the somatic membrane regulate input–output function of human neocortex fast-spiking interneurons.
    HCEMM-EMBL partnersip conference, Heidelberg, Germany, 9. 2022.

Balazs Németh, HCEMM-USZ Translational Pancreatology Research Group

Genomic Instability and Cancer

Antal Berényi, HCEMM-USZ Magnetotherapeutics Research Group

  • Andrea Pejin: Closed-loop stimulation of infralimbic cortex reduces anxiety and prevents fear generalization during memory consolidation and reconsolidation.
    IBRO Workshop, Budapest, Hungary, 1. 2022.
  • Lívia Barcsai: Controlling pathologic fear expression through closed-loop brain stimulation.
    IBRO Workshop, Budapest, Hungary, 1. 2022.
  • Qun Li: Reinstating olfactory bulb derived limbic gamma oscillations alleviates depression.
    IBRO Workshop, Budapest, Hungary, 1. 2022.
  • Tamás Földi: TERMINATING HUMAN EPILEPTIC SEIZURES BY CLOSED-LOOP TRANSCRANIAL BRAIN STIMULATION – A FIRST-IN-PATIENT STUDY.
    IBRO Workshop, Budapest, Hungary, 1. 2022.

Csaba Bödör, HCEMM – SU Molecular Oncohematology Research Group

  • Bátai Bence: Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of targetable EZH2 mutations in follicular lymphoma.
    EHA2023 Hybrid Congress, Frankfurt, 6. 2023.
  • Bedics Gábor: Az első ROS1-transzlokált non-Langerhans sejtes histiocytosis eset detektálása komprehenzív genomikai profilozás segítségével.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • László Tamás: Az immunglobulin-nehézláncgén variábilis régiój (IGHV) mutációs-státuszának meghatározása újgenerációs-szekvenálással krónikus limfocitás leukémiában.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Péterffy Borbála: Potenciális új biomarkerek azonosítása az akut limfoblasztos leukémia központi idegrendszeri érintettségének meghatározására.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Lili Kotmayer: Screening for BCL2 mutations in a real-world cohort of patients with chronic lymphocytic leukemia during venetoclax therapy.
    The ERIC International Meeting, New Frontiers in CLL Research, Barcelona, Spain, 10. 2022.
  • Tamás László: Frequent low-burden TP53 mutations in chronic lymphocytic leukemia detected by next generation sequencing.
    The ERIC International Meeting, New Frontiers in CLL Research, Barcelona, Spain, 10. 2022.
  • Gábor Bedics: Comprehensive Genomic Profiling Reveals Possible Targeted Treatment Options and Novel Variants in Pediatric Primary Central Nervous System Tumors.
    ESMO MAP, Amsterdam, The Netherlands, 10. 2022.
  • Ákos Nagy: Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples yields higher frequency of EZH2 mutations in follicular lymphoma .
    SOHO 2022 Annual Meeting, Houston, USA, 9. 2022.
  • Lili Kotmayer: Screening for BCL2 Mutations in a Real-World Cohort of Patients with Chronic Lymphocytic Leukemia during Venetoclax Therapy.
    ESH 2nd Translational Research Conference on Chronic Lymphocytic Leukemia, Paris, France, 3. 2022.
  • Szilvia Krizsán: Genomic and Transcriptomic Characterization of Hungarian Pediatric Acute Lymphoblastic Leukemia Patients.
    ESH 3rd How to Diagnose and Treat Acute Leukaemias, Budapest, 3. 2022.
  • Lili Kotmayer: Screening for BCL2 Mutations in a Real-World Cohort of Patients with Chronic Lymphocytic Leukemia during Venetoclax Therapy.
    ESH 2nd Translational Research Conference on Chronic Lymphocytic Leukemia, Paris, France, 3. 2022.
  • Ákos Nagy: Non-Invasive Quantitative Analysis of EZH2 Mutations in Follicular Lymphoma.
    SOHO 2021 Annual Meeting, Houston, USA, 9. 2021.

Lajos Haracska, HCEMM-BRC Mutagenesis and Carcinogenesis Research Group

  • Ádám Sánta: Comparative analysis of BRCA1 variants of unknown significance captured by molecular diagnostic testing.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Alexandra Gráf: Comparative analysis of BRCA1 variants of unknown significance captured by molecular diagnostic testing.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Alexandra Gráf: Less is More! – Estimating the Inter-rater reliability of Ten Machine Learning-Based Algorithms in BRCA1 and BRCA2 Missense Variants.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Bertalan Takács: Impacts of COVID-19 on the Microbiome: A Bioinformatics and Machine Learning Study.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Bertalan Takács: Less is More! – Estimating the Inter-rater reliability of Ten Machine Learning-Based Algorithms in BRCA1 and BRCA2 Missense Variants.
    PHD-Postdoc Symposium, HCEMM, , Eger, Hungary, 11. 2022.
  • Erda Qorri: Less is More! – Estimating the Inter-rater reliability of Ten Machine Learning-Based Algorithms in BRCA1 and BRCA2 Missense Variants.
    PHD-Postdoc Symposium, HCEMM, , Eger, Hungary, 11. 2022.
  • Ernő Kiss: Less is More! – Estimating the Inter-rater reliability of Ten Machine Learning-Based Algorithms in BRCA1 and BRCA2 Missense Variants.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Ernő Kiss: Discovery of small-molecule inhibitors of Rad6 function and the Rad6-Rad18 interaction.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Gaurav Sharma: Discovery of small-molecule inhibitors of Rad6 function and the Rad6-Rad18 interaction.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Lajos Haracska: Less is More! – Estimating the Inter-rater reliability of Ten Machine Learning-Based Algorithms in BRCA1 and BRCA2 Missense Variants.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Lajos Haracska: Discovery of small-molecule inhibitors of Rad6 function and the Rad6-Rad18 interaction.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Márton Zsolt Enyedi: Comparative analysis of BRCA1 variants of unknown significance captured by molecular diagnostic testing.
    PHD-Postdoc Symposium, HCEMM, , Eger, Hungary, 11. 2022.
  • Márton Zsolt Enyedi: Less is More! – Estimating the Inter-rater reliability of Ten Machine Learning-Based Algorithms in BRCA1 and BRCA2 Missense Variants.
    PHD-Postdoc Symposium, HCEMM, , Eger, Hungary, 11. 2022.
  • Márton Zsolt Enyedi: Impacts of COVID-19 on the Microbiome: A Bioinformatics and Machine Learning Study.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Ernő Kiss: Comparative analysis of BRCA1 variants of unknown significance captured by molecular diagnostic testing.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 11. 2022.
  • Lajos Haracska: The role of ZBTB1 at the stalled replication fork.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 10. 2022.
  • Alexandra Gráf: Running in Circles: Exploring the Impact of Type 1 Circularity on the Performance of Machine Learning-Based Prediction Algorithms.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Bertalan Takács: Running in Circles: Exploring the Impact of Type 1 Circularity on the Performance of Machine Learning-Based Prediction Algorithms.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Emese Deng: Characterization Of Mesenchymal Stem Cell Senescence By Single-Cell RNA-Seq Using 10x Chromium.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Erda Qorri: Running in Circles: Exploring the Impact of Type 1 Circularity on the Performance of Machine Learning-Based Prediction Algorithms.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Erda Qorri: Characterization Of Mesenchymal Stem Cell Senescence By Single-Cell RNA-Seq Using 10x Chromium.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Ernő Kiss: Running in Circles: Exploring the Impact of Type 1 Circularity on the Performance of Machine Learning-Based Prediction Algorithms.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Lajos Haracska: Comparative analysis of BRCA1 variants of unknown significance captured by molecular diagnostic testing.
    HCEMM PHD-Postdoc Symposium, Eger, Hungary, 9. 2022.
  • Lajos Haracska: Running in Circles: Exploring the Impact of Type 1 Circularity on the Performance of Machine Learning-Based Prediction Algorithms.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Lajos Haracska: Characterization Of Mesenchymal Stem Cell Senescence By Single-Cell RNA-Seq Using 10x Chromium.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Márton Zsolt Enyedi: Characterization Of Mesenchymal Stem Cell Senescence By Single-Cell RNA-Seq Using 10x Chromium.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 9. 2022.
  • Alexandra Gráf: Concordant or not? Performance and concordance rates analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes.
    21st European Conference on Computational Biology, , Sitges, Barcelona, Spain, 9. 2022.
  • Bertalan Takács: Impacts of COVID-19 on the Microbiome: A Bioinformatics and Machine Learning Study.
    21st European Conference on Computational Biology, Sitges, Barcelona, Spain, 9. 2022.
  • Bertalan Takács: Concordant or not? Performance and concordance rates analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes.
    21st European Conference on Computational Biology, , Sitges, Barcelona, Spain, 9. 2022.
  • Erda Qorri: Concordant or not? Performance and concordance rates analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes.
    21st European Conference on Computational Biology, , Sitges, Barcelona, Spain, 9. 2022.
  • Erda Qorri: Comparative analysis of BRCA1 variants of unknown significance captured by molecular diagnostic testing.
    PHD-Postdoc Symposium, HCEMM, , Eger, Hungary, 9. 2022.
  • Ernő Kiss: Concordant or not? Performance and concordance rates analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes.
    21st European Conference on Computational Biology, , Sitges, Barcelona, Spain, 9. 2022.
  • Lajos Haracska: Impacts of COVID-19 on the Microbiome: A Bioinformatics and Machine Learning Study.
    21st European Conference on Computational Biology, Sitges, Barcelona, Spain, 9. 2022.
  • Márton Zsolt Enyedi: Concordant or not? Performance and concordance rates analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes.
    21st European Conference on Computational Biology, , Sitges, Barcelona, Spain, 9. 2022.
  • Márton Zsolt Enyedi: Impacts of COVID-19 on the Microbiome: A Bioinformatics and Machine Learning Study.
    21st European Conference on Computational Biology, Sitges, Barcelona, Spain, 9. 2022.
  • Kata Dudás: The role of ZBTB1 at the stalled replication fork.
    EMBL Summer School in Bioinformatics, Hinxton, England, 6. 2022.
  • Ernő Kiss: High-throughput screening for small molecule modulators of the PCNA ubiquitination cascade.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Ernő Kiss: Assessing the performance of ten pathogenicity prediction algorithms on a dataset of missense BRCA1 and BRCA2 mutations.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Lajos Haracska: Concordant or not? Performance and concordance rates analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes.
    21st European Conference on Computational Biology, , Sitges, Barcelona, Spain, 5. 2022.
  • Alexandra Gráf: Assessing the performance of ten pathogenicity prediction algorithms on a dataset of missense BRCA1 and BRCA2 mutations.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Bertalan Takács: Assessing the performance of ten pathogenicity prediction algorithms on a dataset of missense BRCA1 and BRCA2 mutations.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Erda Qorri: Assessing the performance of ten pathogenicity prediction algorithms on a dataset of missense BRCA1 and BRCA2 mutations.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Gaurav Sharma: High-throughput screening for small molecule modulators of the pcna ubiquitination cascade.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Lajos Haracska: Assessing the performance of ten pathogenicity prediction algorithms on a dataset of missense BRCA1 and BRCA2 mutations.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Lajos Haracska: High-throughput screening for small molecule modulators of the PCNA ubiquitination cascade.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.
  • Márton Zsolt Enyedi: Running in Circles: Exploring the Impact of Type 1 Circularity on the Performance of Machine Learning-Based Prediction Algorithms.
    20th Genetics Workshops in Hungary, Szeged, Hungary, 5. 2022.
  • Márton Zsolt Enyedi: Assessing the performance of ten pathogenicity prediction algorithms on a dataset of missense BRCA1 and BRCA2 mutations.
    Straub Days at the Biological Research Centre, Szeged, Hungary, 5. 2022.

Tibor Pankotai, Genome Integrity and DNA Repair Core Group

Máté Manczinger, HCEMM-BRC Systems Immunology Research Group

  • Máté Manczinger: The joint effect of HLA class I and II alleles shapes antitumor immunity in melanoma patients.
    AACR Special Conference: Tumor Immunology and Immunotherapy, Boston, MA. Philadelphia (PA), 10. 2022.
  • Máté Manczinger: Synergism between HLA class I and II alleles shapes antitumor immunity in melanoma patients.
    EMBL Partnership conference, Heidelberg, Gerrmany, 9. 2022.

Lőrinc Sándor Pongor, Cancer genomics and epigenetics

  • Kolos Nemes: Predicting drug response in small cell lung cancer cell lines using gene expression signatures.
    Hungarian Molecular Life Sciences, Eger, Hungary, 3. 2023.

Lajos Vince Kemény, HCEMM-SU Translational Dermatology Research Group

  • Dorottya Pál: Identification of regulators of ferroptotic cell death in melanoma.
    Semmelweis Symposium 2022, Budapest, Hungary, 11. 2022.
  • Alexandra Lakatos: Overcoming resistance to immune-checkpoint blockade due to deficient antigen presentation in melanoma using in vivo crispr screens.
    HCEMM PhD-Post Symposium 2022, Egerszalók, Hungary, 11. 2022.
  • Dorottya Pál: Identification of regulators of ferroptotic cell death in melanoma.
    HCEMM PhD Symposium 2022, Egerszalók, Hungary, 11. 2022.
  • Lajos Vince Kemény: Skin-derived beta-endorphin mediates radiation therapy fatigue.
    ESDR 2022, Amsterdam, Netherlands, 9. 2022.
  • Alexandra Lakatos: Overcoming resistance to immune-checkpoint blockade due to deficient antigen presentation in melanoma using in vivo crispr screens.
    Semmelweis Symposium , Budapest, Hungary, 11. 2002.

Infectious Diseases with special emphasis on Co-Morbidities

Christoph Sensen, Circulating Nucleic Acid Biomarker Research Group

Viktória Lázár, HCEMM-BRC Pharmacodynamic Drug Interaction Research Group

Advances Core Facilities

Ferhan Ayaydin, HCEMM-USZ Functional Cell Biology and Immunology

  • Divya Teja Dondapati: Plant cell immunolocalization and the use of advanced imaging techniques at HCEMM Advanced Core Facility.
    BRC days, Szeged, 5. 2023.
  • Ferhan Ayaydin: The Development of Imaging Setup for Whole Cell-Based Biosensor.
    FEBS Practical Course, Functional imaging of cellular dynamics, Amsterdam, The Netherlands, 6. 2022.

Zsuzsanna Darula, HCEMM-BRC Single Cell Omics

  • Vanda Varga-Zsíros: Lipidmetabolikus változások a tumoragresszivitás hátterében.
    52. Membrán-transzport konferencia, Sümeg, Hungary, 5. 2023.
  • Vanda Varga-Zsíros: Lipidmetabolikus változások a tumoragresszivitás hátterében.
    52. Membrán-transzport konferencia, Sümeg, Hungary, 5. 2023.
  • Deng Emese: SINGLE-CELL RNA-SEQ REVEALS HETEROGENEOUS DISTRIBUTION OF SENESCENT CANINE MESENCHYMAL STEM CELLS.
    Straub days, Szeged, Hungary, 5. 2023.
  • Deng Emese: SINGLE-CELL RNA-SEQ REVEALS HETEROGENEOUS DISTRIBUTION OF SENESCENT CANINE MESENCHYMAL STEM CELLS.
    Straub days, Szeged, Hungary, 5. 2023.
  • Erda Qorri: Pawsing to Compare: A comprehensive screen of the canine genome against the CellAge Database.
    Straub days, Szeged, Hungary, 5. 2023.
  • Erda Qorri: Pawsing to Compare: A comprehensive screen of the canine genome against the CellAge Database.
    Straub days, Szeged, Hungary, 5. 2023.
  • Deng Emese: Single-cell RNA-SEQ reveals heterogeneous distribution of senescent mesenchymal stem cells..
    Hungarian Molecular Life Sciences, Eger, Hungary, 3. 2023.
  • Deng Emese: Single-cell RNA-SEQ reveals heterogeneous distribution of senescent mesenchymal stem cells..
    Hungarian Molecular Life Sciences, Eger, Hungary, 3. 2023.
  • Erda Qorri: Decoding canine senescence: a single-cell RNAsequencing and bioinformatics approach..
    Hungarian Molecular Life Sciences, Eger, Hungary, 3. 2023.
  • Erda Qorri: Decoding canine senescence: a single-cell RNAsequencing and bioinformatics approach..
    Hungarian Molecular Life Sciences, Eger, Hungary, 3. 2023.
  • Deng Emese: Characterization of Mesenchymal Stem Cell senescence by single cell RNA-seq using 10x Chromium.
    HCEMM PhD Symposium , Egerszalók, Hungary, 11. 2022.
  • Deng Emese: Characterization of Mesenchymal Stem Cell senescence by single cell RNA-seq using 10x Chromium.
    HCEMM PhD Symposium , Egerszalók, Hungary, 11. 2022.
  • Vanda Varga-Zsíros: Laser dissection-coupled quantitative microlipidomic method to resolve tumor heterogeneity.
    GISM 2022 Annual meeting, Turin, Italy, 10. 2022.
  • Vanda Varga-Zsíros: Laser dissection-coupled quantitative microlipidomic method to resolve tumor heterogeneity.
    GISM 2022 Annual meeting, Turin, Italy, 10. 2022.
  • Deng Emese: Characterization of Mesenchymal Stem Cell senescence by single cell RNA-seq using 10x Chromium.
    Genetika Műhelyek Magyarországon XXI. Konferencia, Szeged, Hungary, 9. 2022.
  • Deng Emese: Characterization of Mesenchymal Stem Cell senescence by single cell RNA-seq using 10x Chromium.
    Genetika Műhelyek Magyarországon XXI. Konferencia, Szeged, Hungary, 9. 2022.
  • Bertalan Takács: Impacts of COVID-19 on the Microbiome: A Bioinformatics and Machine Learning Study.
    21st European Conference on Computational Biology (ECCB2022), Sitges, Spain, 9. 2022.
  • Bertalan Takács: Impacts of COVID-19 on the Microbiome: A Bioinformatics and Machine Learning Study.
    21st European Conference on Computational Biology (ECCB2022), Sitges, Spain, 9. 2022.
  • Erda Qorri: Concordant or not? Performance and concordance rate analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes..
    EMBL Partnership conference, Heidelberg, Germany, 9. 2022.
  • Erda Qorri: Concordant or not? Performance and concordance rate analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes..
    EMBL Partnership conference, Heidelberg, Germany, 9. 2022.
  • Erda Qorri: Concordant or not? Performance and concordance rate analysis of ten prediction algorithms on clinically relevant variants from the BRCA1 and BRCA2 genes..
    EMBL Partnership conference, Heidelberg, Germany, 9. 2022.
  • Zsuzsanna Darula: Proteomics validation of a diagnostic gene panel overexpressed in clear cell renal cell carcinoma.
    EMBL Partnership conference, Heidelberg, Germany, 9. 2022.
  • Zsuzsanna Darula: Proteomics validation of a diagnostic gene panel overexpressed in clear cell renal cell carcinoma.
    EMBL Partnership conference, Heidelberg, Germany, 9. 2022.
  • Walliyulahi Ajibola: Seeking novel antimicrobials derived from environmental bacteria.
    EMBO Workshop:New Approaches to Combat Antibiotic Resistant Bacteria NACARB,2022, Ascona, Switzerland, 6. 2022.
  • Walliyulahi Ajibola: Seeking novel antimicrobials derived from environmental bacteria.
    EMBO Workshop:New Approaches to Combat Antibiotic Resistant Bacteria NACARB,2022, Ascona, Switzerland, 6. 2022.
  • Áron Bartha: Világossejtes vesedaganat és normál vese szövet proteom és transzkriptom szintű célzott elemzése.
    51. Membrán-Transzport Konferencia , Sümeg, Hungary, 5. 2022.
  • Áron Bartha: Világossejtes vesedaganat és normál vese szövet proteom és transzkriptom szintű célzott elemzése.
    51. Membrán-Transzport Konferencia , Sümeg, Hungary, 5. 2022.
  • Ádám Pap: Analysis of urinary O-glycopeptides: Systematic evaluation of a dataset using different search engines.
    Straub days 2022, Szeged, Hungary, 5. 2022.
  • Éva Hunyadi-Gulyás: Proteomic analysis of Botrytis cinerea induced noble rot development of Furmint grape berries.
    Straub days 2022, Szeged, Hungary, 5. 2022.
  • Éva Hunyadi-Gulyás: Proteomic analysis of Botrytis cinerea induced noble rot development of Furmint grape berries.
    Straub days, Szeged, Hungary, 5. 2022.
  • Éva Klement: Quantitation using stable isotope labelled peptides to set up a diagnostic protein panel in the differentiation of renal carcinoma and normal kidney tissue.
    Straub days 2022, Szeged, Hungary, 5. 2022.
  • Éva Klement: Quantitation using stable isotope labelled peptides to set up a diagnostic protein panel in the differentiation of renal carcinoma and normal kidney tissue.
    Straub days, Szeged, Hungary, 5. 2022.
  • Vanda Varga-Zsíros: Investigation of tumor heterogeneity: a novel, laser microdissection-coupled lipidomic method.
    Straub days 2022, Szeged, Hungary, 5. 2022.
  • Vanda Varga-Zsíros: Investigation of tumor heterogeneity: a novel, laser microdissection-coupled lipidomic method.
    Straub days, Szeged, Hungary, 5. 2022.
  • Ádám Pap: Analysis of urinary O-glycopeptides: Systematic evaluation of a dataset using different search engines.
    Straub days, Szeged, Hungary, 5. 2022.
  • Ádám Pap: Analysis of urinary O-glycopeptides: Systematic evaluation of a dataset using different search engines.
    XIV Annual Congress of the European Proteomic Association, Leipzig, Germany, 4. 2022.
  • Ádám Pap: Analysis of urinary O-glycopeptides: Systematic evaluation of a dataset using different search engines.
    Proteomic Forum / EUPA 2022 Congress, Leipzig, Germany, 4. 2022.
  • Éva Hunyadi-Gulyás: Proteomic analysis of Botrytis cinerea induced noble rot development of Furmint grape berries.
    XIV Annual Congress of the European Proteomic Association, Leipzig, Germany, 4. 2022.
  • Éva Hunyadi-Gulyás: Proteomic analysis of Botrytis cinerea induced noble rot development of Furmint grape berries.
    Proteomic Forum / EUPA 2022 Congress, Leipzig, Germany, 4. 2022.
  • Éva Klement: Quantitation using stable isotope labelled peptides to set up a diagnostic protein panel in the differentiation of renal carcinoma and normal kidney tissue.
    XIV Annual Congress of the European Proteomic Association, Leipzig, Germany, 4. 2022.
  • Éva Klement: Quantitation using stable isotope labelled peptides to set up a diagnostic protein panel in the differentiation of renal carcinoma and normal kidney tissue.
    Proteomic Forum / EUPA 2022 Congress, Leipzig, Germany, 4. 2022.
  • Áron Bartha: Differentiation of normal and malignant kidney tissues using proteome based AI algorithm.
    Applied Bioinformatics in Life Sciences , Leuven, Belgium, 3. 2022.
  • Áron Bartha: Differentiation of normal and malignant kidney tissues using proteome based AI algorithm.
    Applied Bioinformatics in Life Sciences , Leuven, Belgium, 3. 2022.
  • Áron Bartha: Differentiation of normal and malignant kidney tissues using proteome based AI algorithm.
    Applied Bioinformatics in Life Sciences , Leuven, Belgium, 3. 2022.
  • Áron Bartha: Discriminating malignant and healthy kidney tissues using proteomic and transcriptomic data. .
    Hungarian Molecular Life Science Conference 2021, Eger, Hungary, 11. 2021.
  • Éva Klement: Ion mobility for in-depth proteomics of complex biological mixtures.
    Hungarian Molecular Life Science Conference , Eger, Hungary, 11. 2021.
  • Áron Bartha: Genes discriminating tumor and normal tissues using proteomic and transcriptomic data in renal cell carcinoma..
    European Association for Cancer Research AI in Cancer Diagnostics: from research to clinical practice, , 10. 2021.
  • Áron Bartha: A multi-omic approach to discriminate tumor and normal cells in renal clear cell carcinoma. .
    14th Annual Meeting of the Korean Society of Medical Oncology & 2021 International Conference – KSMO 2021, , 9. 2021.
  • Áron Bartha: Transcriptome and proteome-based study of malignant and healthy kidney tissues. .
    PhD Scientific Days 2021, Budapest, Hungary, 7. 2021.
  • Áron Bartha: Normal and malignant kidney tissue distinction using proteome level and transcriptomic data. .
    Semmelweis Symposium, Best poster award, Budapest, Hunagry, 6. 2021.

Domokos Máthé, HCEMM-SU In Vivo Imaging

  • Domokos Máthé: Prognostic significance of FDG-PET derived conventional and textural parameters in high grade B cell lymphoma.
    European Association of Nuclear Medicine and Molecular Imaging Annual Congress, Barcelona, Spain, 10. 2021.
7 January 2024

Presentations

Immuno-inflammatory Diseases

Edit Buzás, HCEMM-SU Extracellular Vesicles Research Group

  • Edit Buzás: Microvesicles in health and disease..
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 12. 2021.

Prof. András Dinnyés, HCEMM-USZ StemCell Research Group

  • András Dinnyés: Genetikailag újraprogramozott őssejtek felhasználása a regenerációs medicina területén.
    Project Management Institute Budapest, Hungarian Chapter “Lunch & Learn Webinar” c. rendezvényén, Hungary, 5. 2022.
  • András Dinnyés: Disznószív átültetés emberbe. Kutatás az “örök fiatalságért”.
    Interjú Dr. Dinnyés Andrással a Magyar Katolikus Rádió “Kerengő” c. műsorában, Hungary, 4. 2022.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Heti TV “Heti Jégbüfé” c. műsorában, Hungary, 2. 2022.
  • András Dinnyés: .
    Dr. Dinnyés András előadása az ELTE Radnóti Miklós Gyakorlóiskola X Hischool Pályaválasztási Fesztiválon, Hungary, 1. 2022.
  • András Dinnyés: A meghalt kutyákat már több helyen klónozzák – De milyen lesz a másolat házikedvenc?.
    Tudás.hu online cikkben interjú , Hungary, 1. 2022.
  • András Dinnyés: Sertésszív ültetése emberbe, xenotranszplantáció.
    Interjú Dr. Dinnyés Andrással a Kossuth Rádió “Felfedező” c. műsorában, Hungary, 1. 2022.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a HiScool Alapítvány által szervezett pályaorientációs nap alkalmából, Hungary, 12. 2021.
  • András Dinnyés: Mesterségesen létrehozott szövetek és szervek őssejtekből- A regenerációs orvoslás lehetőségei.
    Előadás. Civil Közösségi Ház , Gödöllő, Hungary, 11. 2021.
  • András Dinnyés: Stem cell biology in basic research and diseases.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.
  • Veréb Zoltán: Cell-based therapies: advanced therapy medicinal products.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.
  • András Dinnyés: Modelling Alzheimer’s disease pathology through multilineage differentiation of disease-specific human induced pluripotent stem cells.
    EMBO Workshop: Microglia 2021, Heidelberg, Germany, 10. 2021.
  • András Dinnyés: Regenerative medicine solutions for type 1 diabetes: The iNanoBit project.
    BIOCEV Regeneration 1Vestec, Vestec, Czech Republic, 9. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a HírTV “Radar” c. műsorában, Hungary, 9. 2021.
  • András Dinnyés: Dolly, a ballerina.
    Online cikkben interjú: Magyar Nemzet (Lugas rovat) , Hungary, 7. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Laikus TV “Kódolatlan” c. műsorában, Hungary, 7. 2021.
  • András Dinnyés: New approach methods (NAMs) for developmental neurotoxicology using human iPSC-derived 2D and 3D neuronal models. .
    Advanced Organotypic Models for Toxicological Screening, , 5. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Kossuth Rádió “Felfedező” c. műsorában, Hungary, 4. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Klubrádió “Utópia” c. Műsorában, Hungary, 3. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Magyar Katolikus Rádió “A héten történt – Előtérben a háttér” c. műsorában, Hungary, 3. 2021.
  • András Dinnyés: .
    Kerekasztal beszelgetes Dinnyés Andrással a CEU “Határtalan Tudás” c. rendezvényén, Hungary, 2. 2021.
  • András Dinnyés: Van, aki még a vakcinákat is elutasítja, nemhogy egy sertésszívet.
    Qubit online cikkben interjú, Hungary, 2. 2021.
  • András Dinnyés: Génszerkeszett babák? Megszűnő betegségek? Örök élet? – bioetikai kérdések és válaszok.
    Online Cikk. Szeretlek Magyarország, Dinnyés András nyilatkozatával , Hungary, 2. 2021.
  • András Dinnyés: .
    Interjú Dinnyés Andrással a Kossuth Rádió, “Napközben” c. műsorában, Hungary, 1. 2021.

Balázs Enyedi, HCEMM-SU Inflammatory Signaling Research Group

  • Balázs Enyedi: Mechanisms of tissue damage induced inflammation.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 9. 2021.

Prof. Attila Gácser, HCEMM-USZ Fungal Pathogens Research Group

Prof. Lajos Kemény, HCEMM-USZ Skin Research Group

  • Lajos Kemény: Patenting or publishing?.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 12. 2021.
  • András Dinnyés: Interjú Dr. Dinnyés Andrással a Klubrádió “Utópia” c. műsorában, Hungary, 11. 2021.
  • Fanni Balogh: HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Máté Manczinger: Big data and personalized medicine. Drug repurposing – two for the price of one..
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.

Bálint Kintses, HCEMM-BRC Translational Microbiology Research Group

  • Kintses Bálint: Antibiotic resistance.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 9. 2021.
  • Bálint Kintses: Progress report.
    Group Leader – SAP – AFC Meeting 2021, Hungary, 6. 2021.

József Maléth, HCEMM-USZ Molecular Gastroenterology Research Group

  • József Maléth: The inhibition of the mitochondrial Na+/Ca2+ exchanger prevents acinar cell damage in acute pancreatitis in mice.
    Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, 6. 2022.
  • József Maléth: CFTR activity is determined by the store-independent activation of SPCA2/STIM1/ORAI1 complex in secretory epithelial cells.
    17th ECFS (European Cystic Fibrosis Society) Basic Science Conference, Albufeira, Portugal, 3. 2022.
  • József Maléth : Translational research in gastroenterology.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.

Karolina Pircs, HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group

  • Karolina Pircs: Direct neural conversion: New possibilities to model human ageing .
    HCEMM Retreat, Vargatanya, 6. 2023.
  • Roland Zsoldos: Studying DNA repair in Huntington’s disease USING DIRECTLY REPROGRAMMED PATIENT-DERIVED induced neurons.
    TMI-Floormeeting, Budapest, Hungary, 5. 2023.
  • Bendeguz Sramko: Direct reprogramming and neural differentiation of dental pulp cells.
    TMI-Floormeeting, Budapest, Hungary, 4. 2023.
  • Karolina Pircs: BŐRSEJTBŐL AGYSEJT: SEJTPROGRAMOZÁS ALAPFOKON.
    Kecskemét High School Students -National Academy of Scientist Education (NASE) program , Kecskemét, 3. 2023.
  • Balázs Kis: AMPK targeting mini drug-screening for functional recovery in Huntington’s disease patient derived induced neurons.
    TMI-Floormeeting, Budapest, Hungary, 3. 2023.
  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts. HunDoc, Budapest, Hungary, 1. 2023.
  • Karolina Pircs: Stem cells: applications to neuroscience. BRIDGE-Translational Excellence Programme, , 9. 2022.
  • Bendegúz Sramkó: The Wisdom in Teeth: Neural differentiation of dental pulp cells. National Academy of Sciences audit, Szeged, Hungary, 9. 2022.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon. Researchers Night, , 7. 2022.
  • Karolina Pircs: HCEMM Overview. MÉT 84th Annual Meeting – Annual Conference of the Hungarian Society for Microcirculation and Vascular Biology , Budapest, Hungary, 7. 2022.
  • Karolina Pircs: DIRECT NEURAL CONVERSION: NEW POSSIBILITIES TO MODEL LATE-ONSET NEURODEGENERATIVE DISEASES . HUPHAR60: Pharmaceutical Research, Innovation and Pharmacokinetics, Mártafüred, Hungary, 6. 2022.
  • Karolina Pircs: Making a transation to a group leader role. EMBL Careers Webinars, , 6. 2022.
  • Karolina Pircs: Direct neural conversion: New possibilities to model human ageing and age-related neurodegenerative diseases . HCEMM-SZU , Szeged, Hungary, 6. 2022.
  • Karolina Pircs: Distinct subcellular autophagy impairments in induced neurons from Huntington’s disease patients . EMBO Autophagy Workshop, Eger, Hungary, 6. 2022.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon. Researchers Night, , 3. 2022.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases. EMBL-HCEMM Group Leader meeting, Heidelberg, Germany, 3. 2022.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases. EMBL-HCEMM Group Leader meeting, Heidelberg, Germany, 3. 2022.
  • Karolina Pircs: MiND+: A new drug screening strategy for age-related cognitive disorders using induced neurons directly reprogrammed from patient’s fibroblasts. MultiPark Innovation Talk, Lund, Sweden, 2. 2022.
  • Karolina Pircs: Model-iN. Inauguration Ceremony of the Incubator House, Szeged, Hungary, 1. 2022.
  • Karolina Pircs: Model-iN. Inauguration Ceremony of the Incubator House, Szeged, Hungary, 1. 2022.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration. HCEMM PhD Symposium, Siófok, Hungary, 11. 2021.
  • Danics Lea: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration. HCEMM PhD Symposium, Siófok, Hungary, 11. 2021.
  • Karolina Pircs: How to make a great impression? Tricks and hints for the HCEMM Interview presentation. HCEMM Junior GL Tranining, Budapest, Hungary, 9. 2021.
  • Karolina Pircs: How to make a great impression? Tricks and hints for the HCEMM Interview presentation. HCEMM Junior GL Tranining, Budapest, Hungary, 9. 2021.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases. Biological therapies and vaccines: safety issues, physiological and immunological mechanisms (Summer School for PhD students and young researchers), , 6. 2021.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases. Biological therapies and vaccines: safety issues, physiological and immunological mechanisms (Summer School for PhD students and young researchers), , 6. 2021.
  • Karolina Pircs: Model-iN. Group Leader – SAP – AFC Meeting 2022, Varga tanya, Hungary, 6. 2021.
  • Karolina Pircs: Model-iN. HCEMM „Researcher Retreat” , Vargatanya, Hungary, 6. 2021.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon. Researchers Night, , 11. 2020.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon. Researchers Night, , 11. 2020.

Metabolic and Cardiovascular Diseases

László Csanády, HCEMM-SU Molecular Channelopathies Research Group

Eszter Farkas, HCEMM- USZ Cerebral Blood Flow and Metabolism Research Group

Nazha Hamdani, HCEMM-SU Cardiovascular Comorbidities Research Group

Balázs Papp, HCEMM-BRC Metabolic Systems Biology Research Group

  • Balázs Papp: Towards a Darwinian approach to evaluate personal metabolome profiles.
    HCEMM Group Leader Meeting, Kerekegyháza,Hungary, 6. 2023.
  • Balázs Papp: Evolution in front of our eyes.
    popular science talk as part of the National Academy of Scientist Education programme, Kecskemét, Hungary, 3. 2023.
  • Eszter Ari: Global map of evolutionary dependencies between antibiotic resistance and virulence genes in E. coli. Bioinformatics, Celebrating the Hungarian Science (HAS, Research Centre for Natural Sciences), Budapest, Hungary, 11. 2022.
  • Eszter Ari: Impact of restrictive measures in Hungary on the spread and genetic diversity of SARS-CoV-2 virus. BRC-SZAB COVID19 series of scientific lectures, , 11. 2021.
  • Eszter Ari: Evolutionary study of Hungarian coronavirus genomes. Researcher’s Night, Budapest, Hungary, 11. 2020.
  • Eszter Ari: Evolutionary study of Hungarian coronavirus genomes. Tudományok Fővárosa, Budapest, Hungary, 10. 2020.
  • Roland Tengölics: Accelerated metabolome evolution of S. cerevisiae. Darwin Days, Tihany, Hungary, 2. 2020.

Zoltán Varga, HCEMM-SU Cardiometabolic Immunology Research Group

  • Varga Zoltán: David Karadi, Zotan Varga. WCP 2023, Glasgow, 7. 2023.
  • Tamás Gergely: CARDIOTOXICITY OF ANTI-PD-1 IMMUNE CHECKPOINT INHIBITOR IN MICE WITH PRIOR CARDIAC ISCHEMIC INJURY. SE PhD napok, Budapest, 6. 2023.
  • Onódi Zsófia: AIM2-driven inflammasome activation in heart failure: repositioning of probenecid?.
    GPTS, Ulm, Germany, 3. 2023.
  • Vörös Imre: Pharmacokinetic characteristics of a microRNA mimic after intravenous injection in mice.
    MKT 2023. évi Tudományos Kongresszusa, Balatonfüred, Hungary, 5. 2023.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by Next Generation Sequencing and validated by droplet digital PCR .
    28th Kraków Conference on Endothelium and 10th Cardiovascular Research Days, Krakow, Poland, 12. 2022.
  • Tamás Gergely: Molecular characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals IL-17A as a driver of cardiac dysfunction after anti-PD-1 treatment.
    28th Kraków Conference on Endothelium and 10th Cardiovascular Research Days, Krakow, Poland, 12. 2022.
  • Kovács Tamás: The role of melanoma subtypes in immune checkpoint inhibitor related cardiotoxicity – project plans.
    HCEMM PhD – Postdoc Symposium 2022, Egerszalók, Hungary, 11. 2022.
  • Onódi Zsófia: Distinct patterns of inflammasome signalling in the cardiac and skeletal muscle from murine models of Duchenne muscular dystrophy.
    HCEMM retreat 2022, Egerszalók, Hungary, 11. 2022.
  • Onódi Zsófia: Distinct patterns of inflammasome signalling in the cardiac and skeletal muscle from murine models of Duchenne muscular dystrophy.
    IACS, Szeged, Hungary, 9. 2022.
  • Onódi Zsófia: A kardiovaszkuláris kutatásbna alkalmazott sejtvonalak és primer sehtkultúrák összehasonlító vizsgálata.
    HUPHAR 2022, Mátrafüred, Hungary, 6. 2022.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
    PhD Days 2021, Budapest, Hungary, 7. 2021.

Nikolett Wohner, HCEMM-SU Thrombosis and Hemostasis Research Group

Lamsa Karri, Human neuron physiology and therapy Core Group

  • Viktor Szegedi: Novel diagnostics of Alzheimer Disease.
    Interview for radio, qupit podcast, Budapest, Hungary, 5. 2023.
  • Karri Lamsa: It is hard for human fast-spiking neuron to be a fast-spiker.
    University seminar series, Amsterdam Vrije University, Netherlands, 5. 2023.
  • Karri Lamsa: Nerve cells in human brain are special.
    IPM magazine interview, Budapest, Hungary, 4. 2023.
  • Karri Lamsa: Fascilitated electrical reactivity of human neurons.
    NeuroNex Journal Club, Yale University School of Medicine, USA, 3. 2023.
  • Karri Lamsa: It is hard for human fast-spiking neuron to be a fast-spiker.
    University seminar series, Amsterdam Vrije University, Netherlands, 5. 2023.
  • Karri Lamsa: Fascilitated electrical reactivity of human neurons.
    NeuroNex Journal Club, Yale University School of Medicine, USA, 3. 2023.
  • Karri Lamsa: Recording from resected human brain tissue.
    UniQure gene therapy company, Amsterdam Netherlands, 1. 2023.
  • Karri Lamsa: Understanding ‘uniqueness’ of human cortical neurons.
    METT 2022 Physiology meeting, Budapest, Hungary, 6. 2022.

Balazs Németh, HCEMM-USZ Translational Pancreatology Research Group

Genomic Instability and Cancer

Antal Berényi, HCEMM-USZ Magnetotherapeutics Research Group

  • Antal Berenyi: Transzkraniális elektromos stimuláció epilepsziában .
    Mind Clinic Seminars, Budapest, Hungary, 3. 2022.

Csaba Bödör, HCEMM – SU Molecular Oncohematology Research Group

  • Bödör Csaba: Újgenerációs szekvenálás és bioinformatikai algoritmusok alkalmazása a mindennapi molekuláris diagnosztikában.
    Elixir Hungary Konferencia 2023, Budapest, 5. 2023.
  • Bödör Csaba: Az újgenerációs szekvenálás nyújtotta lehetőségek a mindennapi molekuláris diagnosztikában.
    Semmelweis NGS workshop, Budapest, 5. 2023.
  • Bátai Bence: Térbeli heterogenitás vizsgálata follicularis lymphomában újgenerációs szekvenálással.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Bekő Anna: Optikai genomtérképezés alkalmazása akut leukémiák vizsgálatában: a digitális citogenomika bevezetésével szerzett első hazai tapasztalatok.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Bödör Csaba: A krónikus limfocitás leukémia korszerű molekuláris diagnosztikája.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Kotmayer Lili: Nagy granuláris lymphocytás leukémia – diagnosztikai kihívások a patológus szemével.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Péterffy Borbála: Új biomarkerek azonosítása átfogó molekuláris profilozással gyermekkori akut limfoblasztos leukémiában: A Magyar Gyermekleukémia Molekuláris Profilozási Program első három évének eredményei.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Varga Luca: Molekuláris alcsoport-klasszifikáció diffúz nagy B-sejtes limfómában: A hazaiDLBCL molekuláris profilozás program első eredményei.
    Magyar Hematológiai és Transzfuziológiai Társaság XXIX. Kongresszusa, Esztergom, 5. 2023.
  • Bedics Gábor: Klinikailag releváns genetikai mintázat feltárása ATRX vesztő, IDH vad-típusú high-grade gliómák komprehenzív genomikai profilozása által.
    Fiatal Patológusok Találkozója 2023, Siófiok, 3. 2023.
  • Bedics Gábor: Az első ROS1-transzlokált non-Langerhans sejtes histiocytosis eset detektálása komprehenzív genomikai profilozás segítségével.
    Fiatal Patológusok Találkozója 2023, Siófiok, 3. 2023.
  • László Tamás: Szubklonális TP53 mutációk előfordulása és klinikai relevanciája krónikus limfocitás leukémiában.
    Fiatal Patológusok Találkozója 2023, Siófiok, 3. 2023.
  • Péterffy Borbála: Új génfúziók és biomarkerek azonosítása átfogó molekuláris profilozással gyermekkori akut limfoblasztos leukémiában.
    Fiatal Patológusok Találkozója 2023, Siófok, 3. 2023.
  • Bödör Csaba: Korszerű technológiai módszerek az immunológiai és molekuláris pathológiában.
    Pécsi Immunonkológiai Napok, Pécs, 2. 2023.
  • Csaba Bödör: Molecular Diagnostics of Chronic Lymphocytic Leukemia State of the art.
    Online educational meeting, Astra-Zeneca, Online , Virtual, 1. 2022.
  • Csaba Bödör: Importance of molecular genetics in oncohematology.
    Scientific meeting organized by the Szeged local committee of the Hungarian Academy of Sciences, Szeged, Hunagary, 3. 2021.

Lajos Haracska, HCEMM-BRC Mutagenesis and Carcinogenesis Research Group

  • Lajos Haracska: Molecular players of rescuing the replication fork stalled at damaged DNA.
    GINOP-2.3.2-15-2016-000024 Closing Conference, Szeged, Hungary, 8. 2022.
  • Lajos Haracska: Replication of damaged DNA.
    HCEMM Group Leader Meeting, Kerekegyháza, Hungary, 6. 2022.
  • Lajos Haracska: Genomic instability and cancer.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.

Tibor Pankotai, Genome Integrity and DNA Repair Core Group

Máté Manczinger, HCEMM-BRC Systems Immunology Research Group

Lőrinc Sándor Pongor, Cancer genomics and epigenetics

Lajos Vince Kemény, HCEMM-SU Translational Dermatology Research Group

  • Lajos Vince Kemény: Kutatás a bőrgyógyászatban.
    Kutatók éjszakája, Budapest, Hungary, 09. 2022.

Infectious Diseases with special emphasis on Co-Morbidities

Christoph Sensen, Circulating Nucleic Acid Biomarker Research Group

  • Christoph Sensen: Molecular markers.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, okt. 2021.

Viktória Lázár, HCEMM-BRC Pharmacodynamic Drug Interaction Research Group

Advances Core Facilities

Ferhan Ayaydin, HCEMM-USZ Functional Cell Biology and Immunology

  • Ferhan Ayaydin: Advanced applications of confocal laser scanning microscopy.
    Advanced fluorescence microscopy techniques in cell biology and tissue culture (As part of course series held in USZ Faculty of Science and Informatics), Szeged, Hungary, apr. 2022.

Zsuzsanna Darula, HCEMM-BRC Single Cell Omics

  • Walliyulahi Ajibola: Isolation and engineering of soil bacteria producing novel antimicrobial peptides.
    Straub days, Szeged, Hungary, 5. 2023.
  • Walliyulahi Ajibola: Isolation and engineering of soil bacteria producing novel antimicrobial peptides.
    Straub days, Szeged, Hungary, 5. 2023.
  • Balogh Gábor: Egysejt lipidomika.
    51. Membrán-transzport konferencia, Sümeg, Hungary, 5. 2022.
  • Gyöngyi Cinege: Horizontally transferred genes are required for an effective innate immune response.
    Straub days, Szeged, Hungary, 5. 2022.
  • Zsuzsanna Darula: The Advanced Core Facility network of HCEMM.
    HCEMM inauguration ceremony, Szeged, Hungary, 1. 2022.
  • Zsuzsanna Darula: The Advanced Core Facility network of HCEMM.
    HCEMM inauguration ceremony, Szeged, Hungary, 1. 2022.
  • Éva Klement: FAIMS – proteomikai alkalmazások.
    MS Szakmai Nap, , 12. 2021.
  • Bartha Áron: Világossejtes veserák és normál vese transzkriptom és proteom szintű célzott elemzése
    XXXIV. MOT Kongresszus, Szeged, Hungary, 11. 2021.
  • Eszter Farkas: Do microglia contribute to cerebral vasoregulation? .
    EMBO Workshop: Microglia 2021, Heidelberg, Germany, 10. 2021.

Domokos Máthé, HCEMM-SU In Vivo Imaging

  • Domokos Máthé: Copper-64 / Actinium-225-human anti-PSCA-IgG4 theranostics of a prostate cancer model.
    Deutsche Gesellschaft für Nuklearmedizin, Hannover, Germany, 4. 2021.
7 January 2024

Conferences

Immuno-inflammatory Diseases

Edit Buzás, HCEMM-SU Extracellular Vesicles Research Group

  • Edit Buzás: Overview and Background on Extracellular vesicles.
    2nd Lugano Exo Day, Lugano, Switzerland, 4. 2022.
  • Edit Buzás: Paradigm shifts in extracellular vesicle biology.
    CNR-EV-NET first workshop, Rome, Italy, 4. 2022.
  • Edit Buzás: Extracellular vesicle trafficking.
    About Frontiers in CardioVascular Biology (FCVB) , Budapest, Hungary, 4. 2022.
  • Brachyahu Meir Kestecher: EV-LDL Association – Finding A Link to Atherosclerosis.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Edit Buzás: Extracellular vesicles: lessons in vitro, ex vivo and in vivo.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Edit Buzás: Contamination of extracellular vesicle preparations or biomolecular corona around around extracellular vesicles?.
    1st Meeting of the Portugese Network on Extracellular Vesicles, Porto, Portugal, 9. 2021.
  • Edit Buzás: Interactions of the extracellular vesicle surface.
    2nd EVITA Symposium, Ciocco, Italy, 9. 2021.

Prof. András Dinnyés, HCEMM-USZ StemCell Research Group

  • Viktória Király: In vitro neurotoxicological studies using differentiated SH-SY5Y cells.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • András Dinnyés: Humán pluripotens őssejt technológiai platform a betegségmodellezés és a regenerációs medicina területén.
    Magyar Személyre Szabott Medicina Társaság XI. konferenciája, Mátrafüred, Hungary, 8. 2021.
  • András Dinnyés: New approach methods (NAMs) for developmental neurotoxicology using human iPSC-derived 2D and 3D neuronal models.
    Webinar Series: “Advanced Organotypic Models for Toxicological Screening”, , 4. 2021.

Balázs Enyedi, HCEMM-SU Inflammatory Signaling Research Group

  • Balázs Enyedi : Detecting extracellular gradients of inflammatory mediators with novel genetically encoded fluorescent biosensors.
    Straub days 2022, Szeged, Hungary, 5. 2022.
  • László Fazekas: Investigating tissue damage induced calcium signaling in zebrafish.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Szimonetta Tamás: Development of a genetically encoded LTB4 sensor.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Balázs Enyedi : The role of the nucleus in mediating tissue damage detection.
    ISCTICO-HUPHAR-IUPHAR-Joint-Conference, Pécs, Hungary, 10. 2021.

Prof. Attila Gácser, HCEMM-USZ Fungal Pathogens Research Group

  • Attila Gácser: Studying the potential of “trained immunity” in human oral epithelial cells using Candida species.
    5th Meeting of Middle Europe Societies of Immunology and Allergology (MESIA), Prague, Czech Republic, 11. 2022.
  • Attila Gácser: Acquisition of antifungal resistance influences virulence attributes of C. auris microevolved strains in mouse systemic fungal infection model.
    Annual Meeting of the Hungarian Society for Microbiology – 2022, Kecskemét, Hungary, 10. 2022.
  • Attila Gácser: The phagolysosomal zinc ion homeostasis of M1 type human macrophages and the effect of Interferon-γ on the macrophage-Candida parapsilosis interaction.
    51th Annual Meeting of the Hungarian Society for Immunology, Kecskemét, Hungary, 10. 2022.
  • Attila Gácser: Investigation of the effect of extracellular vesicles secreted by Candida albicans and candidalysin on the progression of oral squamous cell carcinoma.
    51th Annual Meeting of the Hungarian Society for Immunology, Kecskemét, Hungary, 10. 2022.
  • Attila Gácser: Candida albicans enhances the development and progression of oral squamous cell carcinoma in vitro and in vivo.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, 5. 2022.
  • Attila Gácser: Candida albicans enhances the development and progression of oral squamous cell carcinoma in vitro and in vivo.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, 5. 2022.
  • Éva Veres: Investigation of the interaction between Candida extracellular vesicles and oral squamous cell carcinoma cell lines.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Attila Gácser: Investigation of the interaction between Candida extracellular vesicles and oral squamous cell carcinoma cell lines.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, 10. 2021.

Prof. Lajos Kemény, HCEMM-USZ Skin Research Group

  • Dr. Máté Manczinger: A mutációs szignatúrák hatása a tumorok immunogenitására.
    50th Annual Meeting of the Hungarian Society for Immunology, Kecskemét, Hungary, 10. 2021.
  • Prof. Dr. Lajos Kemény: Mesenchymal stromal cell therapy for psoriasis.
    50th Annual European Society for Dermatological Research Meeting (ESDR), , 9. 2021.
  • Prof. Dr. Zsuzsanna Bata-Csörgő: Drug induced urticaria and angioedema.
    30th EADV Congress, , 9. 2021.
  • Dr. Beáta Szilvia Bolla: A Cutibacterium acnes szerepének vizsgálata a sebgyógyulási folyamatokban in vitro modell rendszerekben.
    93th Annual Meeting of the Hungarian Dermatological Society, , 11. 2020.
  • Dr. Judit Danis: Az IL-23A génexpresszió szabályozásának vizsgálata keratinocitákban.
    93th Annual Meeting of the Hungarian Dermatological Society, , 11. 2020.
  • Dr. Renáta Bozó: Stresszfehérjék vizsgálata a pikkelysömörös tünetmentes bőrben.
    93th Annual Meeting of the Hungarian Dermatological Society, , 11. 2020.
  • Fanni Balogh: A bőr veleszületett immun memória folyamatainak vizsgálata keratinocitákban.
    93th Annual Meeting of the Hungarian Dermatological Society, , 11. 2020.
  • Dr. Renáta Bozó: Stresszfehérjék a pikkelysömörös tünetmentes bőrsejtekben.
    49th Annual Meeting of the Hungarian Society for Immunology, , 10. 2020.
  • Prof. Dr. Zsuzsanna Bata-Csörgő: A pikkelysömör immunológiája.
    49th Annual Meeting of the Hungarian Society for Immunology, , 10. 2020.

József Maléth, HCEMM-USZ Molecular Gastroenterology Research Group

  • József Maléth: Polarity-changed human pancreatic epithelial organoids provide advanced accessibility to apical membrane physiology.
    MGT-Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, 6. 2022.
  • József Maléth: CFTR activity is determined store-independently by SCPA2/STIM1/ORAI1 complex in secretory epithelial cells.
    MGT-Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, 6. 2022.
  • József Maléth: Serum and mucosal Serpin E1 concentration reflects to the endoscopic activity and therapy response in inflammatory bowel disease – potential new activity marker.
    Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, 6. 2022.
  • József Maléth: CFTR activity is determined by the store-independent activation of SPCA2/STIM1/ORAI1 complex in secretory epithelial cells.
    European Pancreatic Club – The 53rd meeting of EPC, , 6. 2022.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    52nd Annual Meeting of the American Pancreas Association, Miami, USA, 11. 2021.
  • József Maléth: Characterizing 2D and 3D Organoid Cultures Derived from Mouse and Human Pancreas Specimens.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Viktória Szabó: Characterizing 2D and 3D Organoid Cultures Derived from Mouse and Human Pancreas Specimens.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    29th United European Gastroenterology Week, , 10. 2021.
  • József Maléth: Increased expression of Serpin E1, a potential new activity marker, reflects endoscopic activity and therapeutic non-response in inflammatory bowel disease.
    United European Gastroenterology Week 2021, Virtual, 10. 2021.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    A Magyar Gasztroenerológiai Társaság 63. Nagygyűlése, , 6. 2021.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    European Pancreatic Club – The 53rd meeting of EPC, , 6. 2021.

Karolina Pircs, HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group

  • Karolina Pircs: Indukált neuronok: Új lehetőségek az öregedéshez köthető neurodegeneratív betegségek modellezésére.
    GMO Minisymposia, Pécs, 4. 2023.
  • Lea Danics: PHOSPHOPROTEOMIC ANALYSIS REVEALS POST-TRANSCRIPTIONAL DYSREGULATION IN HUNTINGTON’S DISEASE PATIENT DERIVED INDUCED NEURONS. 2nd HCEMM PhD and Postdoc Symposium, Egerszalók, Hungary, 11. 2022.
  • Lea Danics: PHOSPHOPROTEOMIC ANALYSIS REVEALS POST-TRANSCRIPTIONAL DYSREGULATION IN HUNTINGTON’S DISEASE PATIENT DERIVED INDUCED NEURONS. EMBO Partnership Conference 2022, Heidelberg, Germany, 9. 2022.
  • Lea Danics: Bőrsejtből agysejt – Sejtprogramozás alapfokon. Kutatók Éjszakája 2022, Budapest, Hungary, 9. 2022.
  • Danics Lea: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration. HunDoc22, Budapest, Hungary, 1. 2022.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x005F_x000B_in human aging and neurodegeneration. HunDoc22, Budapest, Hungary, 1. 2022.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration. HunDoc22, Budapest, Hungary, 1. 2022.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x005F_x000B_in human aging and neurodegeneration. HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Karolina Pircs: . EHDN 2021 Remote Meeting, , 9. 2021.
  • Karolina Pircs: . EHDN 2021 Remote Meeting, , 9. 2021.

Metabolic and Cardiovascular Diseases

László Csanády, HCEMM-SU Molecular Channelopathies Research Group

  • Andras Szollosi: Posttranslational modifications of cAMP-dependent protein kinase A affect its binding to the CFTR anion channel. Biophysical Society 67th Annual Meeting, San Diego, CA, USA, 2. 2023.
  • Andras Szollosi: Posttranslational modifications of cAMP-dependent protein kinase A affect its binding to the CFTR anion channel. 2nd HCEMM PHD-POSTDOC symposium, Egerszalók, Hungary, 11. 2022.
  • László Csanády: A CFTR csatorna élettani szabályozása, a cisztikus fibrózis új terápiás célpontjai.
    Magyar Tudomány Ünnepe, Magyar Tudományos Akadémia, Budapest, 11. 2022.
  • Márton Simon: Central role of a conserved serine residue across CFTR molecular evolution. 2nd HCEMM PhD-Postdoc symposium, Egerszalók, Hungary, 11. 2022.
  • Ádám Bartók: A TRPM2 CSATORNA KÖZPONTI HŐÉRZÉKELÉSÉNEK MOLEKULÁRIS HÁTTERE. 51st Meeting of the Hungarian Society for Immunology, Kecskemét, Hungary, 10. 2022.
  • László Csanády: Molecular mechanisms of ivacaftor and CF mutation R117H.
    Cystic Fibrosis Canada (CFC) basic science symposium, McGill University, Montréal, Canada, 5. 2022.
  • Ádám Bartók: The molecular nature oftemperature sensitivity of the TRPM2 channel. 66th Biophysical Society Annual Meeting, San Francisco, CA, USA, 2. 2022.
  • Márton Simon: Revealing the molecular pathophysiology of the cystic fibrosis causing mutation R117H. HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.

Eszter Farkas, HCEMM-USZ Cerebral Blood Flow and Metabolism Research Group

  • Rita Frank: Nimodipine in solution or associated to pH-sensitive nanoparticles attenuates ischemic injury.
    FAMÉ2023, Mátraháza, Hungary, 6. 2023.
  • Eszter Farkas: Spreading depolarization impairs neurovascular coupling in ischemia/reperfusion in mice.
    31st International Symposium on Cerebral Blood Flow and Metabolism, Brisbane, Australia, 6. 2023.
  • Ákos Menyhárt: Neurotoxic astrocyte swelling and dysfunction upon the acute phase of ischemic stroke.
    15th Göttingen Meeting of the German Neuroscience Society, Göttingen, Germany, 3. 2023.
  • Eszter Farkas: Az agyödéma progressziója egér iszkémiás stroke modellben, képalkotó vizsgálatokkal alátámasztva. A Magyar Neuroradiológiai Társaság 2022. évi Kongresszusa, Tapolca, Hungary, 10. 2022.
  • Eszter Farkas: A reperfúziós sérülés mechanizmusának képalkotó vizsgálata globális iszkémia egér modelljében. A Magyar Neuroradiológiai Társaság 2022. évi Kongresszusa, Tapolca, Hungary, 10. 2022.
  • Eszter Farkas: Acidotoxicity in cerebral ischemia: the essential role of spreading depolarization. International Conference on Spreading Depolarizations 2022, Salt Lake City, UT, USA, 10. 2022.
  • Eszter Farkas: The essential role of astrocyte dysfunction in the evolution of spreading depolarization under ischemia. International Conference on Spreading Depolarizations 2022, Salt Lake City, UT, USA, 10. 2022.
  • Eszter Farkas: Spreading depolarization predicts impaired reperfusion in the mouse cerebral cortex. 14th International Conference on Brain Energy Metabolism, Santa Fe, NM, USA, 10. 2022.
  • Eszter Farkas: Az astrocytaduzzadás fokozza az ischaemiás sérülés mértékétAz astrocytaduzzadás fokozza az ischaemiás sérülés mértékét. A Magyar Stroke Társaság XVI. Kongresszusa és a Magyar Neuroszonológiai Társaság XIII. Konferenciája, Siófok, Hungary, 9. 2022.
  • Eszter Farkas: A csökkent kollaterális keringés elégtelen reperfúziót jósol az ischaemiás egér agyban. A Magyar Stroke Társaság XVI. Kongresszusa és a Magyar Neuroszonológiai Társaság XIII. Konferenciája, Siófok, Hungary, 9. 2022.
  • Eszter Farkas: A terjedő depolarizáció gátlása növeli a reperfúzió hatékonyságát egér akut ischaemiás stroke modellben. A Magyar Stroke Társaság XVI. Kongresszusa és a Magyar Neuroszonológiai Társaság XIII. Konferenciája, Siófok, Hungary, 9. 2022.
  • Eszter Farkas: A nimodipin hatása a vascularis reaktivitás öregedéshez és stroke-hoz kapcsolódó sérülésére patkánybanA nimodipin hatása a vascularis reaktivitás öregedéshez és stroke-hoz kapcsolódó sérülésére patkányban. A Magyar Stroke Társaság XVI. Kongresszusa és a Magyar Neuroszonológiai Társaság XIII. Konferenciája, Siófok, Hungary, 9. 2022.
  • Eszter Farkas: Az endothelin-1 szerepe a neurovascularis csatolás sérülésében egér ischaemiás stroke modellben. A Magyar Stroke Társaság XVI. Kongresszusa és a Magyar Neuroszonológiai Társaság XIII. Konferenciája, Siófok, Hungary, 9. 2022.
  • Eszter Farkas: A terjedő depolarizáció neurovascularis diszfunkciót okoz egér ischaemiás stroke modellben. A Magyar Stroke Társaság XVI. Kongresszusa és a Magyar Neuroszonológiai Társaság XIII. Konferenciája, Siófok, Hungary, 9. 2022.
  • Eszter Farkas: Neuronal injury in ischemic stroke: what is the central mechanism? . LXXXIVth Annual Meeting of the Hungarian Physiological Society (MÉT), Budapest, Hungary, 7. 2022.
  • Eszter Farkas: Az agyi iszkémiás sérülések pathomechanizmusai; az életkor, mint cerebrovaszkuláris rizikó faktor. A Magyar Neurológiai Társaság 38. Kongresszusa, Budapest, Hungary, 6. 2022.
  • Eszter Farkas: Sejtmembrán asszociált kórélettani jelenségek az iszkémiás stroke akut fázisában. 51. Membrán-Transzport Konferencia, Sümeg, Hungary, 5. 2022.
  • Eszter Farkas: Autoregulatory failure contributes to hypoperfusion in response to spreading depolarization. Experimental Biology 2022, Philadelphia, USA, 4. 2022.
  • Eszter Farkas: Autoregulatory failure contributes to hypoperfusion in response to spreading depolarization. Experimental Biology 2022, Philadelphia, PA, USA, 4. 2022.
  • Eszter Farkas: A nimodipin hatása a vaszkuláris reaktivitásra az öregedő és a stroke-os patkányagyban. A Magyar Haemorheologiai Társaság XXVIII., a Magyar Mikrocirkulációs és Vaszkuláris Biológiai Társaság és a Magyar Szabadgyök-Kutató Társaság VII. Közös Kongresszusa, Pécs, Hungary, 4. 2022.
  • Eszter Farkas: A neurovaszkuláris csatolás diszfunkciója terjedő depolarizációt követően. A Magyar Haemorheologiai Társaság XXVIII., a Magyar Mikrocirkulációs és Vaszkuláris Biológiai Társaság és a Magyar Szabadgyök-Kutató Társaság VII. Közös Kongresszusa, Pécs, Hungary, 4. 2022.
  • Anna Törteli: The role of spreading depolarization in the insufficiency of reperfusion after cerebrovascular occlusion. HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Eszter Farkas: Do microglia contribute to cerebral vasoregulation?. EMBO Workshop: Microglia 2021, Heidelberg, Germany, 10. 2021.

Nazha Hamdani, HCEMM-SU Cardiovascular Comorbidities Research Group

Balázs Papp, HCEMM-BRC Metabolic Systems Biology Research Group

  • Eszter Ari: Timing of non-pharmaceutical interventions impacts transmission patterns across different waves of the SARS-CoV-2 pandemic: lessons from Hungary.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Roland Tengölics: We bring metabolite levels closer to your research – Service and research at the metabolomics lab of BRC Szeged.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Balázs Papp: Principles of metabolome conservation.
    EMBO Members Meeting 2021, Heidelberg, Germany, 10. 2021.
  • Balázs Papp: Principles of metabolome conservation in animals.
    Metabolic Pathway Analysis Conference, Knoxville, USA, 8. 2021.
  • Balázs Papp: Genomic epidemiology of coronavirus in Hungary.
    Epidemiology and modelling workshop, Kecskemét, Hungary, 7. 2021.
  • Balázs Papp: Evolutionary principles of antimicrobial peptide resistance.
    10th Annual Meeting of the Nordic EMBL Partnership for Molecular Medicine, , 9. 2020.
  • Eszter Ari: Methods to investigate the microbiome and understand the results.
    MGT Colon Section, Visegrád, Hungary, 3. 2020.
  • Dorottya Kalapis: Unraveling the impact of compensatory evolution on metabolic divergence.
    ICSB2019, Okanawa, Japan, 11. 2019.
  • Ádám Györkei: Systematic study of Escherichia coli protein aggregation in vivo.
    Hungarian Society for Bioinformatics: Bioinformatics 2019 conference, Budapest, Hungary, 11. 2019.
  • Balázs Papp: Evolution of the metabolome in yeasts.
    Hungarian Society for Bioinformatics: Bioinformatics 2019 conference, Budapest, Hungary, 11. 2019.
  • Károly Kovács: Compensated deleterious mutations as drivers of morphological evolution.
    23rd Evolutionary Biology Meeting at Marseilles, Marseille, France, 9. 2019.
  • Zsuzsa Sarkadi: Compensatory Mutations Drive Morphological Evolution.
    SMBE 2019, Manchester, UK, 7. 2019.
  • Károly Kovács: Compensated Deleterious Mutations as Drivers of Morphological Evolution.
    Molecular Mechanisms in Evolution (GRS), Gordon Research Seminar, Easton, USA, 6. 2019.
  • Balázs Papp: Impacts of Natural Selection on the Metabolome.
    Molecular Mechanisms in Evolution, Gordon Research Conference, Easton, USA, 6. 2019.

Zoltán Varga, HCEMM-SU Cardiometabolic Immunology Research Group

  • Tamás Gergely: Bempedoic acid does not show hidden cardiotoxic properties and reduces reperfusion-induced arrhythmias in a rat model of myocardial infarction.
    WCP 2023, Glasgow, 7. 2023.
  • Varga Zoltán: Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype.
    ISHR ES, Porto, 6. 2023.
  • Varga Zoltán: CARDIOTOXICITY OF IMMUNE CHECKPOINT INHIBITORS.
    FAMÉ, Mátraháza, 6. 2023.
  • Tamás Gergely: MKT-Richter díj előadás: Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment.
    MKT 2023, Balatonfüred, 5. 2023.
  • Tamás Gergely: Echocardiographic measurements in preclinical models of cardiotoxicity and cardiac diseases.
    Vevo Conference, Prague, 2. 2023.
  • Varga Zoltán: AIM2-driven inflammasome activation in heart failure.
    28th Kraków Conference on Endothelium and 10th Cardiovascular Research Days, Krakow, Poland, 12. 2022.
  • Varga Zoltán: AIM2-driven inflammasome activation in heart failure.
    IACS, Szeged, Hungary, 9. 2022.
  • Varga Zoltán: AIM2-driven inflammasome activation in heart failure.
    FCVB 2022, Budapest, Hungary, 4. 2022.
  • Zoltán Varga: AIM2-driven inflammasome activation in heart failure.
    ESC Frontiers in Cardiovascular Biomedicine conference, Budapest, Hungary, 4. 2022.
  • Dániel Kucsera: Investigating the efficacy of anti IL 1ß monoclonal antibody treatment in an aged mouse model of non alcoholic steatohepatitis.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by droplet digital PCR and validated by Next Generation Sequencing.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Tamás Gergely: Immune checkpoint inhibitor-induced cardiotoxicity is dependent on thymic immune response.
    2021 Congress of Hungarian Society of Cardiology, Balatonfüred, Hungary, 10. 2021.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by droplet digital PCR and validated by Next Generation Sequencing.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Zoltán Varga: New inflammatory mechanisms in chronic heart failure.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Zsófia Onódi : Inflammaszóma aktiváció vizsgálata végstádiumú szívelégtelenségben.
    FAMÉ 2019, Budapest, Hungary, 6. 2019.
  • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
    PhD Days 2019, Budapest, Hungary, 4. 2019.

Lamsa Karri, Human neuron physiology and therapy Core Group

  • Karri Lamsa: Computational specialization of pv+ interneurons in human neocortex.
    ESMED conference, Madrid Spain, 8. 2022.

Genomic Instability and Cancer

Antal Berényi, HCEMM-USZ Magnetotherapeutics Research Group

  • Lívia Barcsai: Electrotherapy of pathological anxiety: Modulating traumatic memories by the electrical stimulation of the brain Berényi.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Antal Berenyi: Oscillotherapy – Closed-loop transcranial electric stimulation in epilepsy and PTSD.
    Society for Brain Mapping and Therapeutics Annual Meeting, Los Angeles, CA, USA, 7. 2021.

Csaba Bödör, HCEMM–SU Molecular Oncohematology Research Group

  • Csaba Bödör: Routine application of comprehensive oncogenomic profiling in onco(hemato)logy in Hungary.
    Turkish National Pathology Congress, Izmir, Turkey, 10. 2022.
  • Csaba Bödör: Implementation of precision medicine in pediatric oncology in Hungary: The Hungarian Pediatric Oncology Molecular Profiling Programme.
    Cutting-Edge Implementation of Precision Medicine in Europe, Stockholm, Sweden, 9. 2022.
  • Gábor Bedics: Novel Copy Number Aberration-based Classification Methods.
    EHA 2022 Hybrid Congress, Vienna, Austria, 6. 2022.
  • Lili Kotmayer: Screening for BCL2 Mutations in a Real-World Cohort of Patients with Chronic Lymphocytic Leukemia during Venetoclax Therapy.
    EHA 2022 Hybrid Congress, Vienna, Austria, 6. 2022.
  • Ákos Nagy: Liquid-biopsy based monitoring of EZH2 mutations in follicular lymphoma: implications for non-invasive disease monitoring and targeted therapy.
    6th Pannonia Pathology Congress, Tále, Slovakia, 5. 2022.
  • Csaba Bödör: Routine application of comprehensive oncogenomic profiling in onco(hemato)logy in hungary .
    6th Pannonia Pathology Congress, Tále, Slovakia, 5. 2022.
  • Csaba Bödör: Defining molecular response to ibrutinib in CLL using single cell immune profiling.
    6th Pannonia Pathology Congress, Tále, Slovakia, 5. 2022.
  • Richard Kiss: Distinct patterns of clonal evolution characterize patients with chronic lymphocytic leukemia treated with novel targeted agents.
    6th Pannonia Pathology Congress, Tále, Slovakia, 5. 2022.
  • Szilvia Krizsán: Comprehensive characterization of pediatric leukemias using next-generation sequencing.
    6th Pannonia Pathology Congress, Tále, Slovakia, 5. 2022.
  • Laura Kiss: Liquid biopsy-based detection and monitoring of EZH2 gene mutations in follicular lymphoma / EZH2 génmutációk kimutatása és nyomonkövetése folyadék-biopsziás mintákból follikuláris limfómában.
    4th RECOOP International Student Conference, Prague, Czech Republic, 4. 2022.
  • Gábor Bedics: Improved Copy Number Aberration-based Genetic Classification Refines Risk Assessment in Pediatric B-cell Acute Lymphoblastic Leukemia.
    ESH 3rd How to Diagnose and Treat Acute Leukaemias, virtual, 3. 2022.
  • Csaba Bödör: Molecular classification and monitoring in diffuse large B-cell lymphomas.
    Annual Meeting of the Hungarian Society for Hematology and Transfusion, Virtual, 11. 2021.
  • Ákos Nagy: Minimal invasive detection and monitoring of EZH2 mutations in follicular lymphoma.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Lili Kotmayer: Sensitive monitoring of therapy resistance n CLL treated with novel targeted therapies.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Csaba Bödör: Molecular pathogenesis and novel biomarkers in B-cell lymphomas.
    Scientific workshop: A celebration of Professor Laszlo Lajtha, Manchester, UK, 10. 2021.
  • Lili Kotmayer: Germline GATA2 mutations in familial MDS/AML: a manually curated online registry from the ERAPERMED GATA2-HuMo international consortium.
    EWOG 9th International Symposium on MDS and SAA in Childhood, Athens, Greece, 9. 2021.
  • Csaba Bödör: State of the art molecular characterization of tumours.
    Conference of the Hungarian Society for Personalised Medicine, Mátraháza, Hungary, 8. 2021.
  • Csaba Bödör: The Promise of Epigenetic Directed Therapies for the Treatment of B-Cell Malignancies.
    Annual Meeting of the European Hematology Association, Virtual, 6. 2021.

Lajos Haracska, HCEMM-BRC Mutagenesis and Carcinogenesis Research Group

  • Kata Dudás: The role of ZBTB1 at the stalled replication fork.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Nargis Karatayeva: Crosstalk between Fanconi anaemia and Rad18 DNA damage tolerance pathways.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.

Tibor Pankotai, Genome Integrity and DNA Repair Core Group

Máté Manczinger, HCEMM-BRC Systems Immunology Research Group

Lőrinc Sándor Pongor, Cancer genomics and epigenetics

  • Lőrinc S. Pongor: Role of Extrachromosomal DNA in Small Cell Lung Cancer Heterogeneity and Plasticity.
    Hungarian Molecular Life Sciences, Eger, Hungary, 3. 2023.

Lajos Vince Kemény, HCEMM-SU Translational Dermatology Research Group

  • Botond Szabolcs: Genetic dependency and compound sensitivity mapping of melanoma based on proteogenomic profiling.
    MDT 2022, Debrecen, Hungary, 9. 2022.
  • Elmar G. Lutz: Utilizing transcriptomic analysis to validate proteomic data associated with progression in melanoma.
    MDT 2022, Debrecen, Hungary, 9. 2022.
  • Lajos Vince Kemény: Skin-derived beta-endorphin mediates radiation therapy fatigue.
    MDT 2022, Debrecen, Hungary, 9. 2022.
  • Lajos Vince Kemény: Skin-derived beta-endorphin mediates radiation therapy fatigue.
    ESDR 2022, Endocrinology section, Amsterdam, Netherlands, 9. 2022.

Infectious Diseases with special emphasis on Co-Morbidities

Christoph Sensen, Circulating Nucleic Acid Biomarker Research Group

Viktória Lázár, HCEMM-BRC Pharmacodynamic Drug Interaction Research Group

Advances Core Facilities

Ferhan Ayaydin, HCEMM-USZ Functional Cell Biology and Immunology

  • Ferhan Ayaydin: Mobile biosensor development at the FCBI Advanced Core Facility.
    FEBS Practical Course, Functional imaging of cellular dynamics, Amsterdam, The Netherlands, 6. 2022.

Zsuzsanna Darula, HCEMM-BRC Single Cell Omics

  • Gábor Balogh: Are 3D cultures able to model in vivo tumor behavior? A spatial lipidomics and multiomics investigation..
    63rd International Conference on the Bioscience of Lipids (ICBL), Palma de Mallorca, Spain, 10. 2023.
  • Pap Ádám: Mass spectrometric characterization of O-glycopeptides.
    FEBS3+ XXVII Biochemistry Congress, Stary Smokovec, Slovakia, 9. 2023.
  • Zsuzsanna Darula: Negotiating the Maze of O-glycosylation.
    IMSC 2022 conference, Maastricht, The Netherlands, 8. 2022.
  • Zsuzsanna Darula: Negotiating the Maze of O-glycosylation.
    IMSC 2022 conference, Maastricht, The Netherlands, 8. 2022.
  • Gábor Balogh: Egysejt lipidomika.
    51. Membrán-transzport konferencia, Sümeg, Hungary, 5. 2022.
  • Gyöngyi Cinege: Horizontally transferred genes are required for an effective innate immune response.
    Straub days 2022, Szeged, Hungary, 5. 2022.
  • Gábor Balogh: Development of a laser dissection-coupled quantitative microlipidomic method to resolve tumor heterogeneity. .
    International Conference on the Bioscience of Lipids , Utrecht, The Netherlands, 10. 2021.
  • Bartha Áron: Normál és világossejtes vesedaganat proteom és transzkriptom szintű célzott elemzése. .
    MOT Fiatal Onkológusok Szekciójának X. Konferenciája , Budapest, Hungary, 9. 2021.

Domokos Máthé, HCEMM-SU In Vivo Imaging

  • Domokos Máthé: Theranostics in Radiopharmacy: The basic research and translational perspectives gained from molecular imaging. International Postgraduate Conference on Radiopharmacy, Izmir, Turkey, 6. 2021.
  • Domokos Máthé : Immuno-imaging and Imaging of Fibrosis: Preparations for Post-COVID-19 Translational Results. Biomedical Applications in Translational Research, Karaikudi, India, 5. 2020.
7 January 2024

Add Your Heading Text Here

This website uses cookies. For more information visit the Cookies & Privacy Policy page.
Skip to content